Trial Outcomes & Findings for A Brief Cognitive Task Intervention for NHS Staff Affected by COVID-19 Trauma (GAINS-2 Study) (NCT NCT05616676)
NCT ID: NCT05616676
Last Updated: 2026-05-27
Results Overview
Number of intrusive memories of traumatic event(s) recorded by participants in a brief daily online diary for 7 days.
COMPLETED
NA
122 participants
Run-in/screening week, Week 4 (all arms)
2026-05-27
Participant Flow
Between 08 December 2022 and 15 September 2023, 176 participants were screened via online questionnaires, with 122 eligible participants subsequently providing informed consent and commencing the run-in/screening week.
Prior to randomisation, nine participants were excluded for having fewer than three IMs in the baseline IM diary, eight were lost to follow-up, and six withdrew prior to randomisation. These participants are detailed in the 'Run-in week only (non-randomised)' arm in the Participant Flow.
Participant milestones
| Measure |
Brief Digital Music-listening Task
Access to a brief digital music-listening task for 24 weeks (first 4 weeks with optional researcher support).
Brief digital music-listening task: First session guided by a researcher: Information about the composer's music followed by listening to classical music.
Option to engage in self-administered/guided sessions after the first session.
|
Brief Digital Imagery-competing Task
Access to a brief digital imagery-competing task for 24 weeks (first 4 weeks with optional researcher support).
Brief digital imagery-competing task: First session guided by a researcher: A memory cue followed by playing a computer game with mental rotation instructions.
Option to engage in self-administered/guided sessions after the first session.
|
Treatment As Usual
Access to routine care that participants would otherwise receive if having intrusive memories of traumatic events for 24 weeks.
|
Run-in Week Only (Non-randomised)
This study used a run-in week to establish a baseline number of intrusive memories over a seven-day period.
Participants were randomised if they completed the run-in week, recorded at least three intrusive memories during the run-in week, and completed baseline questionnaires. N=23 participants commenced the run-in week and could not be randomised to experimental arm.
No data are available for those participants were not randomised.
|
|---|---|---|---|---|
|
Run-In/Screening Week
STARTED
|
39
|
40
|
20
|
23
|
|
Run-In/Screening Week
COMPLETED
|
39
|
40
|
20
|
5
|
|
Run-In/Screening Week
NOT COMPLETED
|
0
|
0
|
0
|
18
|
|
Baseline Questionnaires/Randomisation
STARTED
|
39
|
40
|
20
|
5
|
|
Baseline Questionnaires/Randomisation
COMPLETED
|
39
|
40
|
20
|
0
|
|
Baseline Questionnaires/Randomisation
NOT COMPLETED
|
0
|
0
|
0
|
5
|
|
Receive Treatment/TAU Equivalent (Day 0)
STARTED
|
39
|
40
|
20
|
0
|
|
Receive Treatment/TAU Equivalent (Day 0)
COMPLETED
|
35
|
34
|
20
|
0
|
|
Receive Treatment/TAU Equivalent (Day 0)
NOT COMPLETED
|
4
|
6
|
0
|
0
|
|
Week 4
STARTED
|
35
|
34
|
20
|
0
|
|
Week 4
COMPLETED
|
35
|
33
|
20
|
0
|
|
Week 4
NOT COMPLETED
|
0
|
1
|
0
|
0
|
|
Week 12
STARTED
|
35
|
33
|
20
|
0
|
|
Week 12
COMPLETED
|
34
|
31
|
20
|
0
|
|
Week 12
NOT COMPLETED
|
1
|
2
|
0
|
0
|
|
Week 24
STARTED
|
34
|
31
|
20
|
0
|
|
Week 24
COMPLETED
|
34
|
31
|
20
|
0
|
|
Week 24
NOT COMPLETED
|
0
|
0
|
0
|
0
|
Reasons for withdrawal
| Measure |
Brief Digital Music-listening Task
Access to a brief digital music-listening task for 24 weeks (first 4 weeks with optional researcher support).
Brief digital music-listening task: First session guided by a researcher: Information about the composer's music followed by listening to classical music.
Option to engage in self-administered/guided sessions after the first session.
|
Brief Digital Imagery-competing Task
Access to a brief digital imagery-competing task for 24 weeks (first 4 weeks with optional researcher support).
Brief digital imagery-competing task: First session guided by a researcher: A memory cue followed by playing a computer game with mental rotation instructions.
Option to engage in self-administered/guided sessions after the first session.
|
Treatment As Usual
Access to routine care that participants would otherwise receive if having intrusive memories of traumatic events for 24 weeks.
|
Run-in Week Only (Non-randomised)
This study used a run-in week to establish a baseline number of intrusive memories over a seven-day period.
Participants were randomised if they completed the run-in week, recorded at least three intrusive memories during the run-in week, and completed baseline questionnaires. N=23 participants commenced the run-in week and could not be randomised to experimental arm.
No data are available for those participants were not randomised.
|
|---|---|---|---|---|
|
Run-In/Screening Week
Recorded <3 IMs
|
0
|
0
|
0
|
9
|
|
Run-In/Screening Week
Lost to Follow-up
|
0
|
0
|
0
|
5
|
|
Run-In/Screening Week
Withdrawal by Subject
|
0
|
0
|
0
|
3
|
|
Run-In/Screening Week
Withdrawn - sponsor decision not to randomise further participants after conclusion of recruitment
|
0
|
0
|
0
|
1
|
|
Baseline Questionnaires/Randomisation
Withdrawal by Subject
|
0
|
0
|
0
|
2
|
|
Baseline Questionnaires/Randomisation
Lost to Follow-up
|
0
|
0
|
0
|
3
|
|
Receive Treatment/TAU Equivalent (Day 0)
Lost to Follow-up
|
4
|
4
|
0
|
0
|
|
Receive Treatment/TAU Equivalent (Day 0)
Withdrawal by Subject
|
0
|
2
|
0
|
0
|
|
Week 4
Withdrawal by Subject
|
0
|
1
|
0
|
0
|
|
Week 12
Withdrawal by Subject
|
1
|
2
|
0
|
0
|
Baseline Characteristics
A Brief Cognitive Task Intervention for NHS Staff Affected by COVID-19 Trauma (GAINS-2 Study)
Baseline characteristics by cohort
| Measure |
Brief Digital Music-listening Task
n=39 Participants
Access to a brief digital music-listening task for 24 weeks (first 4 weeks with optional researcher support).
Brief digital music-listening task: First session guided by a researcher: Information about the composer's music followed by listening to classical music.
Option to engage in self-administered/guided sessions after the first session.
|
Brief Digital Imagery-competing Task
n=40 Participants
Access to a brief digital imagery-competing task for 24 weeks (first 4 weeks with optional researcher support).
Brief digital imagery-competing task: First session guided by a researcher: A memory cue followed by playing a computer game with mental rotation instructions.
Option to engage in self-administered/guided sessions after the first session.
|
Treatment As Usual
n=20 Participants
Access to routine care that participants would otherwise receive if having intrusive memories of traumatic events for 24 weeks.
Treatment As Usual: Access to routine care that participants would otherwise receive if having intrusive memories of traumatic events.
|
Total
n=99 Participants
Total of all reporting groups
|
|---|---|---|---|---|
|
Age, Continuous
|
43.3 Years
STANDARD_DEVIATION 10.9 • n=51 Participants
|
40.2 Years
STANDARD_DEVIATION 10.4 • n=14 Participants
|
39.1 Years
STANDARD_DEVIATION 8.0 • n=65 Participants
|
41.2 Years
STANDARD_DEVIATION 10.2 • n=24 Participants
|
|
Sex/Gender, Customized
Woman
|
33 Participants
n=51 Participants
|
34 Participants
n=14 Participants
|
18 Participants
n=65 Participants
|
85 Participants
n=24 Participants
|
|
Sex/Gender, Customized
Man
|
6 Participants
n=51 Participants
|
4 Participants
n=14 Participants
|
2 Participants
n=65 Participants
|
12 Participants
n=24 Participants
|
|
Sex/Gender, Customized
Gender-variant/non-binary
|
0 Participants
n=51 Participants
|
1 Participants
n=14 Participants
|
0 Participants
n=65 Participants
|
1 Participants
n=24 Participants
|
|
Sex/Gender, Customized
Other
|
0 Participants
n=51 Participants
|
1 Participants
n=14 Participants
|
0 Participants
n=65 Participants
|
1 Participants
n=24 Participants
|
|
Race/Ethnicity, Customized
Ethnicity · Asian
|
2 Participants
n=51 Participants
|
0 Participants
n=14 Participants
|
1 Participants
n=65 Participants
|
3 Participants
n=24 Participants
|
|
Race/Ethnicity, Customized
Ethnicity · Chinese
|
0 Participants
n=51 Participants
|
1 Participants
n=14 Participants
|
0 Participants
n=65 Participants
|
1 Participants
n=24 Participants
|
|
Race/Ethnicity, Customized
Ethnicity · Mixed
|
1 Participants
n=51 Participants
|
2 Participants
n=14 Participants
|
0 Participants
n=65 Participants
|
3 Participants
n=24 Participants
|
|
Race/Ethnicity, Customized
Ethnicity · White
|
34 Participants
n=51 Participants
|
36 Participants
n=14 Participants
|
19 Participants
n=65 Participants
|
89 Participants
n=24 Participants
|
|
Race/Ethnicity, Customized
Ethnicity · Other
|
2 Participants
n=51 Participants
|
1 Participants
n=14 Participants
|
0 Participants
n=65 Participants
|
3 Participants
n=24 Participants
|
|
Region of Enrollment
United Kingdom
|
39 Participants
n=51 Participants
|
40 Participants
n=14 Participants
|
20 Participants
n=65 Participants
|
99 Participants
n=24 Participants
|
|
Highest level of education
Secondary school (to age 16)
|
1 Participants
n=51 Participants
|
0 Participants
n=14 Participants
|
0 Participants
n=65 Participants
|
1 Participants
n=24 Participants
|
|
Highest level of education
Sixth form or equivalent (to age 18)
|
3 Participants
n=51 Participants
|
2 Participants
n=14 Participants
|
0 Participants
n=65 Participants
|
5 Participants
n=24 Participants
|
|
Highest level of education
Bachelor's degree or equivalent
|
31 Participants
n=51 Participants
|
28 Participants
n=14 Participants
|
13 Participants
n=65 Participants
|
72 Participants
n=24 Participants
|
|
Highest level of education
Master's degree
|
4 Participants
n=51 Participants
|
10 Participants
n=14 Participants
|
7 Participants
n=65 Participants
|
21 Participants
n=24 Participants
|
|
Marital Status
Single
|
7 Participants
n=51 Participants
|
9 Participants
n=14 Participants
|
4 Participants
n=65 Participants
|
20 Participants
n=24 Participants
|
|
Marital Status
Living apart from partner
|
4 Participants
n=51 Participants
|
3 Participants
n=14 Participants
|
0 Participants
n=65 Participants
|
7 Participants
n=24 Participants
|
|
Marital Status
Married or cohabiting
|
21 Participants
n=51 Participants
|
26 Participants
n=14 Participants
|
13 Participants
n=65 Participants
|
60 Participants
n=24 Participants
|
|
Marital Status
Divorced or separated
|
6 Participants
n=51 Participants
|
2 Participants
n=14 Participants
|
3 Participants
n=65 Participants
|
11 Participants
n=24 Participants
|
|
Marital Status
Widowed
|
1 Participants
n=51 Participants
|
0 Participants
n=14 Participants
|
0 Participants
n=65 Participants
|
1 Participants
n=24 Participants
|
|
Marital Status
Other
|
0 Participants
n=51 Participants
|
0 Participants
n=14 Participants
|
0 Participants
n=65 Participants
|
0 Participants
n=24 Participants
|
|
Hours working per week
|
31.7 Hours (per week)
STANDARD_DEVIATION 14.6 • n=51 Participants
|
33.8 Hours (per week)
STANDARD_DEVIATION 13.5 • n=14 Participants
|
39.4 Hours (per week)
STANDARD_DEVIATION 6.2 • n=65 Participants
|
34.1 Hours (per week)
STANDARD_DEVIATION 13.0 • n=24 Participants
|
|
Time as healthcare professional
|
17.7 Years
STANDARD_DEVIATION 12.4 • n=51 Participants
|
15.6 Years
STANDARD_DEVIATION 9.4 • n=14 Participants
|
15.6 Years
STANDARD_DEVIATION 10.0 • n=65 Participants
|
16.4 Years
STANDARD_DEVIATION 10.7 • n=24 Participants
|
|
Employment status
Working full time
|
27 Participants
n=51 Participants
|
30 Participants
n=14 Participants
|
17 Participants
n=65 Participants
|
74 Participants
n=24 Participants
|
|
Employment status
Working part time
|
6 Participants
n=51 Participants
|
5 Participants
n=14 Participants
|
3 Participants
n=65 Participants
|
14 Participants
n=24 Participants
|
|
Employment status
Sick leave
|
2 Participants
n=51 Participants
|
1 Participants
n=14 Participants
|
0 Participants
n=65 Participants
|
3 Participants
n=24 Participants
|
|
Employment status
Student
|
3 Participants
n=51 Participants
|
0 Participants
n=14 Participants
|
0 Participants
n=65 Participants
|
3 Participants
n=24 Participants
|
|
Employment status
Retired
|
1 Participants
n=51 Participants
|
0 Participants
n=14 Participants
|
0 Participants
n=65 Participants
|
1 Participants
n=24 Participants
|
|
Employment status
Other
|
0 Participants
n=51 Participants
|
4 Participants
n=14 Participants
|
0 Participants
n=65 Participants
|
4 Participants
n=24 Participants
|
|
NHS Job Role
Allied Health Professionals
|
3 Participants
n=51 Participants
|
4 Participants
n=14 Participants
|
0 Participants
n=65 Participants
|
7 Participants
n=24 Participants
|
|
NHS Job Role
Doctors
|
1 Participants
n=51 Participants
|
2 Participants
n=14 Participants
|
3 Participants
n=65 Participants
|
6 Participants
n=24 Participants
|
|
NHS Job Role
Healthcare Support Worker
|
4 Participants
n=51 Participants
|
3 Participants
n=14 Participants
|
0 Participants
n=65 Participants
|
7 Participants
n=24 Participants
|
|
NHS Job Role
Nursing
|
16 Participants
n=51 Participants
|
18 Participants
n=14 Participants
|
13 Participants
n=65 Participants
|
47 Participants
n=24 Participants
|
|
NHS Job Role
Other/unknown
|
1 Participants
n=51 Participants
|
0 Participants
n=14 Participants
|
0 Participants
n=65 Participants
|
1 Participants
n=24 Participants
|
|
NHS Job Role
Missing
|
14 Participants
n=51 Participants
|
13 Participants
n=14 Participants
|
4 Participants
n=65 Participants
|
31 Participants
n=24 Participants
|
|
Health Background
Have you been treated for/diagnosed with any mental health problems? · Yes
|
26 Participants
n=51 Participants
|
28 Participants
n=14 Participants
|
16 Participants
n=65 Participants
|
70 Participants
n=24 Participants
|
|
Health Background
Have you been treated for/diagnosed with any mental health problems? · No
|
13 Participants
n=51 Participants
|
12 Participants
n=14 Participants
|
4 Participants
n=65 Participants
|
29 Participants
n=24 Participants
|
|
Health Background
Current mental health problem · Yes
|
16 Participants
n=51 Participants
|
18 Participants
n=14 Participants
|
9 Participants
n=65 Participants
|
43 Participants
n=24 Participants
|
|
Health Background
Current mental health problem · No
|
23 Participants
n=51 Participants
|
22 Participants
n=14 Participants
|
11 Participants
n=65 Participants
|
56 Participants
n=24 Participants
|
|
Health Background
Past mental health problem · Yes
|
11 Participants
n=51 Participants
|
19 Participants
n=14 Participants
|
11 Participants
n=65 Participants
|
41 Participants
n=24 Participants
|
|
Health Background
Past mental health problem · No
|
28 Participants
n=51 Participants
|
21 Participants
n=14 Participants
|
9 Participants
n=65 Participants
|
58 Participants
n=24 Participants
|
|
Health Background
Are you receiving any current treatments/medications for these? · Yes
|
15 Participants
n=51 Participants
|
15 Participants
n=14 Participants
|
10 Participants
n=65 Participants
|
40 Participants
n=24 Participants
|
|
Health Background
Are you receiving any current treatments/medications for these? · No
|
24 Participants
n=51 Participants
|
25 Participants
n=14 Participants
|
10 Participants
n=65 Participants
|
59 Participants
n=24 Participants
|
|
Categories of Work-Related Traumatic Events Experienced
A traumatic or tragic death of a patient
|
35 Participants
n=51 Participants
|
34 Participants
n=14 Participants
|
18 Participants
n=65 Participants
|
87 Participants
n=24 Participants
|
|
Categories of Work-Related Traumatic Events Experienced
A severe or unsuccessful resuscitation
|
25 Participants
n=51 Participants
|
30 Participants
n=14 Participants
|
15 Participants
n=65 Participants
|
70 Participants
n=24 Participants
|
|
Categories of Work-Related Traumatic Events Experienced
Witnessing events surrounding colleague who has fallen ill or died of COVID-19
|
23 Participants
n=51 Participants
|
23 Participants
n=14 Participants
|
9 Participants
n=65 Participants
|
55 Participants
n=24 Participants
|
|
Categories of Work-Related Traumatic Events Experienced
Situation where the care of a patient failed or did not go as planned
|
29 Participants
n=51 Participants
|
29 Participants
n=14 Participants
|
14 Participants
n=65 Participants
|
72 Participants
n=24 Participants
|
|
Categories of Work-Related Traumatic Events Experienced
Threats or violence against healthcare professionals
|
19 Participants
n=51 Participants
|
21 Participants
n=14 Participants
|
12 Participants
n=65 Participants
|
52 Participants
n=24 Participants
|
|
Categories of Work-Related Traumatic Events Experienced
Event involving sudden increased risk of COVID-19 infection
|
26 Participants
n=51 Participants
|
34 Participants
n=14 Participants
|
11 Participants
n=65 Participants
|
71 Participants
n=24 Participants
|
|
Categories of Work-Related Traumatic Events Experienced
A traumatic or tragic event where a patient reminded you of yourself, a family member or friend
|
27 Participants
n=51 Participants
|
26 Participants
n=14 Participants
|
11 Participants
n=65 Participants
|
64 Participants
n=24 Participants
|
|
Categories of Work-Related Traumatic Events Experienced
Event involving extremely distressed/grieving relatives of patients
|
29 Participants
n=51 Participants
|
28 Participants
n=14 Participants
|
15 Participants
n=65 Participants
|
72 Participants
n=24 Participants
|
|
Categories of Work-Related Traumatic Events Experienced
Being faced with suicide / suicide attempt
|
15 Participants
n=51 Participants
|
14 Participants
n=14 Participants
|
7 Participants
n=65 Participants
|
36 Participants
n=24 Participants
|
|
Categories of Work-Related Traumatic Events Experienced
Other
|
7 Participants
n=51 Participants
|
4 Participants
n=14 Participants
|
1 Participants
n=65 Participants
|
12 Participants
n=24 Participants
|
|
Experiences of Prior Trauma
Number of work-related traumatic events experienced/witnessed during COVID-19.
|
19.9 Number of events
STANDARD_DEVIATION 35.0 • n=51 Participants
|
29.3 Number of events
STANDARD_DEVIATION 40.8 • n=14 Participants
|
50.8 Number of events
STANDARD_DEVIATION 94.2 • n=65 Participants
|
29.9 Number of events
STANDARD_DEVIATION 54.7 • n=24 Participants
|
|
Experiences of Prior Trauma
Number of non-work-related traumatic events experienced/witnessed during COVID-19.
|
4.1 Number of events
STANDARD_DEVIATION 7.0 • n=51 Participants
|
3.1 Number of events
STANDARD_DEVIATION 4.6 • n=14 Participants
|
2.2 Number of events
STANDARD_DEVIATION 4.8 • n=65 Participants
|
3.3 Number of events
STANDARD_DEVIATION 5.7 • n=24 Participants
|
|
Timeframe of Work-Related Traumatic Events Experienced
Within the last 24 hours · Selected
|
1 Participants
n=51 Participants
|
4 Participants
n=14 Participants
|
1 Participants
n=65 Participants
|
6 Participants
n=24 Participants
|
|
Timeframe of Work-Related Traumatic Events Experienced
Within the last 24 hours · Not selected
|
38 Participants
n=51 Participants
|
36 Participants
n=14 Participants
|
19 Participants
n=65 Participants
|
93 Participants
n=24 Participants
|
|
Timeframe of Work-Related Traumatic Events Experienced
Within the past month · Selected
|
0 Participants
n=51 Participants
|
1 Participants
n=14 Participants
|
1 Participants
n=65 Participants
|
2 Participants
n=24 Participants
|
|
Timeframe of Work-Related Traumatic Events Experienced
Within the past month · Not selected
|
39 Participants
n=51 Participants
|
39 Participants
n=14 Participants
|
19 Participants
n=65 Participants
|
97 Participants
n=24 Participants
|
|
Timeframe of Work-Related Traumatic Events Experienced
Between 1-3 months ago · Selected
|
0 Participants
n=51 Participants
|
1 Participants
n=14 Participants
|
1 Participants
n=65 Participants
|
2 Participants
n=24 Participants
|
|
Timeframe of Work-Related Traumatic Events Experienced
Between 1-3 months ago · Not selected
|
39 Participants
n=51 Participants
|
39 Participants
n=14 Participants
|
19 Participants
n=65 Participants
|
97 Participants
n=24 Participants
|
|
Timeframe of Work-Related Traumatic Events Experienced
More than 3 months ago · Selected
|
24 Participants
n=51 Participants
|
26 Participants
n=14 Participants
|
16 Participants
n=65 Participants
|
66 Participants
n=24 Participants
|
|
Timeframe of Work-Related Traumatic Events Experienced
More than 3 months ago · Not selected
|
15 Participants
n=51 Participants
|
14 Participants
n=14 Participants
|
4 Participants
n=65 Participants
|
33 Participants
n=24 Participants
|
|
Timeframe of Work-Related Traumatic Events Experienced
Ongoing exposure to traumatic events is part of my job during the COVID-19 pandemic · Selected
|
25 Participants
n=51 Participants
|
17 Participants
n=14 Participants
|
8 Participants
n=65 Participants
|
50 Participants
n=24 Participants
|
|
Timeframe of Work-Related Traumatic Events Experienced
Ongoing exposure to traumatic events is part of my job during the COVID-19 pandemic · Not selected
|
14 Participants
n=51 Participants
|
23 Participants
n=14 Participants
|
12 Participants
n=65 Participants
|
49 Participants
n=24 Participants
|
PRIMARY outcome
Timeframe: Run-in/screening week, Week 4 (all arms)Population: All analyses were completed on an intention-to-treat basis as a between-group comparison.
Number of intrusive memories of traumatic event(s) recorded by participants in a brief daily online diary for 7 days.
Outcome measures
| Measure |
Treatment As Usual
n=20 Participants
Access to routine care that participants would otherwise receive if having intrusive memories of traumatic events for 24 weeks.
Treatment As Usual: Access to routine care that participants would otherwise receive if having intrusive memories of traumatic events.
|
Brief Digital Music-listening Task
n=39 Participants
Access to a brief digital music-listening task for 24 weeks (first 4 weeks with optional researcher support).
Brief digital music-listening task: First session guided by a researcher: Information about the composer's music followed by listening to classical music.
Option to engage in self-administered/guided sessions after the first session.
|
Brief Digital Imagery-competing Task
n=40 Participants
Access to a brief digital imagery-competing task for 24 weeks (first 4 weeks with optional researcher support).
Brief digital imagery-competing task: First session guided by a researcher: A memory cue followed by playing a computer game with mental rotation instructions.
Option to engage in self-administered/guided sessions after the first session.
|
|---|---|---|---|
|
Number of Intrusive Memories of Traumatic Event(s)
Run-in/screening week (Baseline)
|
6.50 Number of intrusive memories
Interval 5.0 to 17.75
|
9.0 Number of intrusive memories
Interval 6.5 to 16.0
|
11.5 Number of intrusive memories
Interval 9.0 to 18.0
|
|
Number of Intrusive Memories of Traumatic Event(s)
Week 4
|
5.0 Number of intrusive memories
Interval 2.5 to 8.0
|
5.0 Number of intrusive memories
Interval 3.0 to 11.5
|
0.5 Number of intrusive memories
Interval 0.0 to 5.0
|
SECONDARY outcome
Timeframe: Run-in/Screening week, Weeks 12 and 24 (all arms)Population: All analyses were completed on an intention-to-treat basis as a between-group comparison.
Number of intrusive memories of traumatic event(s) recorded by participants in a brief daily online diary for 7 days.
Outcome measures
| Measure |
Treatment As Usual
n=20 Participants
Access to routine care that participants would otherwise receive if having intrusive memories of traumatic events for 24 weeks.
Treatment As Usual: Access to routine care that participants would otherwise receive if having intrusive memories of traumatic events.
|
Brief Digital Music-listening Task
n=39 Participants
Access to a brief digital music-listening task for 24 weeks (first 4 weeks with optional researcher support).
Brief digital music-listening task: First session guided by a researcher: Information about the composer's music followed by listening to classical music.
Option to engage in self-administered/guided sessions after the first session.
|
Brief Digital Imagery-competing Task
n=40 Participants
Access to a brief digital imagery-competing task for 24 weeks (first 4 weeks with optional researcher support).
Brief digital imagery-competing task: First session guided by a researcher: A memory cue followed by playing a computer game with mental rotation instructions.
Option to engage in self-administered/guided sessions after the first session.
|
|---|---|---|---|
|
Number of Intrusive Memories of Traumatic Event(s)
Week 24
|
3.0 Number of intrusive memories
Interval 1.0 to 11.5
|
3.0 Number of intrusive memories
Interval 1.75 to 5.25
|
0.0 Number of intrusive memories
Interval 0.0 to 1.0
|
|
Number of Intrusive Memories of Traumatic Event(s)
Run-in/Screening week (Baseline)
|
6.5 Number of intrusive memories
Interval 5.0 to 17.75
|
9.0 Number of intrusive memories
Interval 6.5 to 16.0
|
11.5 Number of intrusive memories
Interval 9.0 to 18.0
|
|
Number of Intrusive Memories of Traumatic Event(s)
Week 12
|
3.0 Number of intrusive memories
Interval 0.0 to 6.5
|
4.50 Number of intrusive memories
Interval 1.25 to 8.0
|
0.0 Number of intrusive memories
Interval 0.0 to 2.0
|
SECONDARY outcome
Timeframe: Baseline, 4 weeks, 12 weeks and 24 weeks (all arms)Population: All analyses were completed on an intention-to-treat basis as a between-group comparison.
This 20-item measure assesses symptoms of PTSD over the last week. Items are rated on a 5-point scale ranging from 0 ("not at all") to 4 ("extremely"). Scores are summed to give a total severity score (ranging 0 to 80), with greater scores indicating greater symptom severity.
Outcome measures
| Measure |
Treatment As Usual
n=20 Participants
Access to routine care that participants would otherwise receive if having intrusive memories of traumatic events for 24 weeks.
Treatment As Usual: Access to routine care that participants would otherwise receive if having intrusive memories of traumatic events.
|
Brief Digital Music-listening Task
n=39 Participants
Access to a brief digital music-listening task for 24 weeks (first 4 weeks with optional researcher support).
Brief digital music-listening task: First session guided by a researcher: Information about the composer's music followed by listening to classical music.
Option to engage in self-administered/guided sessions after the first session.
|
Brief Digital Imagery-competing Task
n=40 Participants
Access to a brief digital imagery-competing task for 24 weeks (first 4 weeks with optional researcher support).
Brief digital imagery-competing task: First session guided by a researcher: A memory cue followed by playing a computer game with mental rotation instructions.
Option to engage in self-administered/guided sessions after the first session.
|
|---|---|---|---|
|
PTSD Checklist for DSM-5 (PCL-5)
Baseline
|
34.95 score on a scale
Standard Deviation 14.12
|
32.64 score on a scale
Standard Deviation 17.14
|
32.35 score on a scale
Standard Deviation 18.23
|
|
PTSD Checklist for DSM-5 (PCL-5)
Week 4
|
30.94 score on a scale
Standard Deviation 14.18
|
26.85 score on a scale
Standard Deviation 17.10
|
13.84 score on a scale
Standard Deviation 8.86
|
|
PTSD Checklist for DSM-5 (PCL-5)
Week 12
|
23.79 score on a scale
Standard Deviation 15.70
|
19.88 score on a scale
Standard Deviation 16.18
|
10.86 score on a scale
Standard Deviation 10.49
|
|
PTSD Checklist for DSM-5 (PCL-5)
Week 24
|
21.29 score on a scale
Standard Deviation 15.83
|
16.08 score on a scale
Standard Deviation 11.89
|
8.42 score on a scale
Standard Deviation 8.32
|
SECONDARY outcome
Timeframe: Baseline, 4 weeks, 12 weeks and 24 weeks (all arms)Population: All analyses were completed on an intention-to-treat basis as a between-group comparison.
This 2-item scale measures sleep problems against the DSM-5 criteria for insomnia disorder. Item responses are each scored 0-4, with scores from 0 to 2 indicating threshold criteria for insomnia disorder. Total score ranges 0-8, with a higher score indicating better sleep.
Outcome measures
| Measure |
Treatment As Usual
n=20 Participants
Access to routine care that participants would otherwise receive if having intrusive memories of traumatic events for 24 weeks.
Treatment As Usual: Access to routine care that participants would otherwise receive if having intrusive memories of traumatic events.
|
Brief Digital Music-listening Task
n=39 Participants
Access to a brief digital music-listening task for 24 weeks (first 4 weeks with optional researcher support).
Brief digital music-listening task: First session guided by a researcher: Information about the composer's music followed by listening to classical music.
Option to engage in self-administered/guided sessions after the first session.
|
Brief Digital Imagery-competing Task
n=40 Participants
Access to a brief digital imagery-competing task for 24 weeks (first 4 weeks with optional researcher support).
Brief digital imagery-competing task: First session guided by a researcher: A memory cue followed by playing a computer game with mental rotation instructions.
Option to engage in self-administered/guided sessions after the first session.
|
|---|---|---|---|
|
Sleep Condition Indicator (SCI)
Week 24
|
3.71 score on a scale
Standard Deviation 2.87
|
4.42 score on a scale
Standard Deviation 2.72
|
5.32 score on a scale
Standard Deviation 2.48
|
|
Sleep Condition Indicator (SCI)
Baseline
|
2.60 score on a scale
Standard Deviation 2.30
|
3.28 score on a scale
Standard Deviation 2.60
|
3.03 score on a scale
Standard Deviation 2.38
|
|
Sleep Condition Indicator (SCI)
Week 4
|
2.82 score on a scale
Standard Deviation 2.81
|
3.93 score on a scale
Standard Deviation 2.93
|
3.96 score on a scale
Standard Deviation 2.27
|
|
Sleep Condition Indicator (SCI)
Week 12
|
3.74 score on a scale
Standard Deviation 2.58
|
4.83 score on a scale
Standard Deviation 2.46
|
4.95 score on a scale
Standard Deviation 2.52
|
SECONDARY outcome
Timeframe: Baseline, 4 weeks, 12 weeks and 24 weeks (all arms)Population: All analyses were completed on an intention-to-treat basis as a between-group comparison.
This 2-item short-form self-report measure assesses symptoms of anxiety. Items are rated for how often they have bothered the respondent over the last two weeks, from 0 ("not at all") to 3 ("nearly every day"). Total score is the sum of both items and ranges from 0 to 6, with greater scores indicating greater symptom severity.
Outcome measures
| Measure |
Treatment As Usual
n=20 Participants
Access to routine care that participants would otherwise receive if having intrusive memories of traumatic events for 24 weeks.
Treatment As Usual: Access to routine care that participants would otherwise receive if having intrusive memories of traumatic events.
|
Brief Digital Music-listening Task
n=39 Participants
Access to a brief digital music-listening task for 24 weeks (first 4 weeks with optional researcher support).
Brief digital music-listening task: First session guided by a researcher: Information about the composer's music followed by listening to classical music.
Option to engage in self-administered/guided sessions after the first session.
|
Brief Digital Imagery-competing Task
n=40 Participants
Access to a brief digital imagery-competing task for 24 weeks (first 4 weeks with optional researcher support).
Brief digital imagery-competing task: First session guided by a researcher: A memory cue followed by playing a computer game with mental rotation instructions.
Option to engage in self-administered/guided sessions after the first session.
|
|---|---|---|---|
|
Generalised Anxiety Disorder 2-item Scale (GAD-2)
Baseline
|
2.90 score on a scale
Standard Deviation 2.17
|
2.44 score on a scale
Standard Deviation 1.76
|
2.90 score on a scale
Standard Deviation 1.91
|
|
Generalised Anxiety Disorder 2-item Scale (GAD-2)
Week 4
|
2.53 score on a scale
Standard Deviation 1.70
|
2.33 score on a scale
Standard Deviation 1.75
|
1.63 score on a scale
Standard Deviation 1.28
|
|
Generalised Anxiety Disorder 2-item Scale (GAD-2)
Week 12
|
2.68 score on a scale
Standard Deviation 2.03
|
1.96 score on a scale
Standard Deviation 1.78
|
1.33 score on a scale
Standard Deviation 1.28
|
|
Generalised Anxiety Disorder 2-item Scale (GAD-2)
Week 24
|
2.06 score on a scale
Standard Deviation 1.75
|
1.50 score on a scale
Standard Deviation 1.38
|
1.16 score on a scale
Standard Deviation 1.11
|
SECONDARY outcome
Timeframe: Baseline, 4 weeks, 12 weeks and 24 weeks (all arms)Population: All analyses were completed on an intention-to-treat basis as a between-group comparison.
This 2-item short-form self-report measure assesses symptoms of depression. Items are rated for how often they have bothered the respondent over the last two weeks, from 0 ("not at all") to 3 ("nearly every day"). Total score is the sum of both items and ranges from 0 to 6, with greater scores indicating greater symptom severity.
Outcome measures
| Measure |
Treatment As Usual
n=20 Participants
Access to routine care that participants would otherwise receive if having intrusive memories of traumatic events for 24 weeks.
Treatment As Usual: Access to routine care that participants would otherwise receive if having intrusive memories of traumatic events.
|
Brief Digital Music-listening Task
n=39 Participants
Access to a brief digital music-listening task for 24 weeks (first 4 weeks with optional researcher support).
Brief digital music-listening task: First session guided by a researcher: Information about the composer's music followed by listening to classical music.
Option to engage in self-administered/guided sessions after the first session.
|
Brief Digital Imagery-competing Task
n=40 Participants
Access to a brief digital imagery-competing task for 24 weeks (first 4 weeks with optional researcher support).
Brief digital imagery-competing task: First session guided by a researcher: A memory cue followed by playing a computer game with mental rotation instructions.
Option to engage in self-administered/guided sessions after the first session.
|
|---|---|---|---|
|
Patient Health Questionnaire 2-item Version (PHQ-2)
Baseline
|
2.25 score on a scale
Standard Deviation 1.97
|
2.10 score on a scale
Standard Deviation 1.59
|
2.10 score on a scale
Standard Deviation 1.43
|
|
Patient Health Questionnaire 2-item Version (PHQ-2)
Week 4
|
2.18 score on a scale
Standard Deviation 2.21
|
1.63 score on a scale
Standard Deviation 1.36
|
0.83 score on a scale
Standard Deviation 0.82
|
|
Patient Health Questionnaire 2-item Version (PHQ-2)
Week 12
|
1.79 score on a scale
Standard Deviation 1.65
|
1.38 score on a scale
Standard Deviation 1.74
|
1.00 score on a scale
Standard Deviation 1.00
|
|
Patient Health Questionnaire 2-item Version (PHQ-2)
Week 24
|
1.47 score on a scale
Standard Deviation 1.50
|
1.04 score on a scale
Standard Deviation 1.27
|
0.76 score on a scale
Standard Deviation 1.01
|
SECONDARY outcome
Timeframe: Baseline, 4 weeks, 12 weeks and 24 weeks (all arms)Population: Analyses were completed on an intention-to-treat basis.
This 19-item self-report measure assesses work engagement and burnout. The work engagement subscale consists of 10 items assessing three dimensions (vigour, attentiveness, dedication). The burnout subscale consists of 9 items assessing three dimensions (exhaustion, disengagement and inattentiveness). Respondents rate how often they have felt each descriptive in the past two weeks, from 1 (not at all) to 4 (all the time). The work engagement subscale total score is calculated as a mean of items (range 1-4), with greater scores indicating greater work engagement.
Outcome measures
| Measure |
Treatment As Usual
n=20 Participants
Access to routine care that participants would otherwise receive if having intrusive memories of traumatic events for 24 weeks.
Treatment As Usual: Access to routine care that participants would otherwise receive if having intrusive memories of traumatic events.
|
Brief Digital Music-listening Task
n=39 Participants
Access to a brief digital music-listening task for 24 weeks (first 4 weeks with optional researcher support).
Brief digital music-listening task: First session guided by a researcher: Information about the composer's music followed by listening to classical music.
Option to engage in self-administered/guided sessions after the first session.
|
Brief Digital Imagery-competing Task
n=40 Participants
Access to a brief digital imagery-competing task for 24 weeks (first 4 weeks with optional researcher support).
Brief digital imagery-competing task: First session guided by a researcher: A memory cue followed by playing a computer game with mental rotation instructions.
Option to engage in self-administered/guided sessions after the first session.
|
|---|---|---|---|
|
Scale of Work Engagement and Burnout (SWEBO) - Work Engagement Total Score
Baseline
|
2.22 score on a scale
Standard Deviation 0.63
|
2.09 score on a scale
Standard Deviation 0.62
|
2.00 score on a scale
Standard Deviation 0.47
|
|
Scale of Work Engagement and Burnout (SWEBO) - Work Engagement Total Score
Week 4
|
2.16 score on a scale
Standard Deviation 0.46
|
2.30 score on a scale
Standard Deviation 0.62
|
2.45 score on a scale
Standard Deviation 0.50
|
|
Scale of Work Engagement and Burnout (SWEBO) - Work Engagement Total Score
Week 12
|
2.41 score on a scale
Standard Deviation 0.62
|
2.54 score on a scale
Standard Deviation 0.66
|
2.35 score on a scale
Standard Deviation 0.47
|
|
Scale of Work Engagement and Burnout (SWEBO) - Work Engagement Total Score
Week 24
|
2.24 score on a scale
Standard Deviation 0.76
|
2.57 score on a scale
Standard Deviation 0.83
|
2.34 score on a scale
Standard Deviation 0.37
|
SECONDARY outcome
Timeframe: Baseline, 4 weeks, 12 weeks and 24 weeks (all arms)Population: Analyses were completed on an intention-to-treat basis.
This 19-item self-report measure assesses work engagement and burnout. The work engagement subscale consists of 10 items assessing three dimensions (vigour, attentiveness, dedication). The burnout subscale consists of 9 items assessing three dimensions (exhaustion, disengagement and inattentiveness). Respondents rate how often they have felt each descriptive in the past two weeks, from 1 (not at all) to 4 (all the time). The work burnout subscale total score is calculated as a mean of items (range 1-4), with greater scores indicating greater work burnout.
Outcome measures
| Measure |
Treatment As Usual
n=20 Participants
Access to routine care that participants would otherwise receive if having intrusive memories of traumatic events for 24 weeks.
Treatment As Usual: Access to routine care that participants would otherwise receive if having intrusive memories of traumatic events.
|
Brief Digital Music-listening Task
n=39 Participants
Access to a brief digital music-listening task for 24 weeks (first 4 weeks with optional researcher support).
Brief digital music-listening task: First session guided by a researcher: Information about the composer's music followed by listening to classical music.
Option to engage in self-administered/guided sessions after the first session.
|
Brief Digital Imagery-competing Task
n=40 Participants
Access to a brief digital imagery-competing task for 24 weeks (first 4 weeks with optional researcher support).
Brief digital imagery-competing task: First session guided by a researcher: A memory cue followed by playing a computer game with mental rotation instructions.
Option to engage in self-administered/guided sessions after the first session.
|
|---|---|---|---|
|
Scale of Work Engagement and Burnout (SWEBO) - Work Burnout Total Score
Baseline
|
2.21 score on a scale
Standard Deviation 0.64
|
2.20 score on a scale
Standard Deviation 0.68
|
2.25 score on a scale
Standard Deviation 0.58
|
|
Scale of Work Engagement and Burnout (SWEBO) - Work Burnout Total Score
Week 4
|
2.21 score on a scale
Standard Deviation 0.55
|
2.05 score on a scale
Standard Deviation 0.63
|
1.69 score on a scale
Standard Deviation 0.33
|
|
Scale of Work Engagement and Burnout (SWEBO) - Work Burnout Total Score
Week 12
|
1.97 score on a scale
Standard Deviation 0.60
|
1.89 score on a scale
Standard Deviation 0.71
|
1.94 score on a scale
Standard Deviation 0.45
|
|
Scale of Work Engagement and Burnout (SWEBO) - Work Burnout Total Score
Week 24
|
2.23 score on a scale
Standard Deviation 0.70
|
1.93 score on a scale
Standard Deviation 0.79
|
1.87 score on a scale
Standard Deviation 0.41
|
SECONDARY outcome
Timeframe: Baseline, 4 weeks, 12 weeks and 24 weeks (all arms)Population: All analyses were completed on an intention-to-treat basis as a between-group comparison.
Single item assessing self-reported number of sick days taken from work in the last 4 weeks.
Outcome measures
| Measure |
Treatment As Usual
n=20 Participants
Access to routine care that participants would otherwise receive if having intrusive memories of traumatic events for 24 weeks.
Treatment As Usual: Access to routine care that participants would otherwise receive if having intrusive memories of traumatic events.
|
Brief Digital Music-listening Task
n=39 Participants
Access to a brief digital music-listening task for 24 weeks (first 4 weeks with optional researcher support).
Brief digital music-listening task: First session guided by a researcher: Information about the composer's music followed by listening to classical music.
Option to engage in self-administered/guided sessions after the first session.
|
Brief Digital Imagery-competing Task
n=40 Participants
Access to a brief digital imagery-competing task for 24 weeks (first 4 weeks with optional researcher support).
Brief digital imagery-competing task: First session guided by a researcher: A memory cue followed by playing a computer game with mental rotation instructions.
Option to engage in self-administered/guided sessions after the first session.
|
|---|---|---|---|
|
Sickness Absence
Baseline
|
1.65 Days
Standard Deviation 3.95
|
2.79 Days
Standard Deviation 6.80
|
1.35 Days
Standard Deviation 3.23
|
|
Sickness Absence
Week 4
|
0.06 Days
Standard Deviation 0.24
|
1.31 Days
Standard Deviation 3.07
|
3.17 Days
Standard Deviation 6.48
|
|
Sickness Absence
Week 12
|
1.32 Days
Standard Deviation 3.46
|
1.21 Days
Standard Deviation 2.55
|
2.19 Days
Standard Deviation 6.10
|
|
Sickness Absence
Week 24
|
0.59 Days
Standard Deviation 1.50
|
2.33 Days
Standard Deviation 6.82
|
0.16 Days
Standard Deviation 0.47
|
SECONDARY outcome
Timeframe: Baseline, 4 weeks, 12 weeks and 24 weeks (all arms)Population: All analyses were completed on an intention-to-treat basis as a between-group comparison.
3 items assess participants' intention to leave their job e.g. "I think a lot about leaving the job", each rated from 1 (strongly agree) to 5 (strongly disagree). The total score ranges 3 to 15, with a lower score indicating stronger intention to leave the job.
Outcome measures
| Measure |
Treatment As Usual
n=20 Participants
Access to routine care that participants would otherwise receive if having intrusive memories of traumatic events for 24 weeks.
Treatment As Usual: Access to routine care that participants would otherwise receive if having intrusive memories of traumatic events.
|
Brief Digital Music-listening Task
n=39 Participants
Access to a brief digital music-listening task for 24 weeks (first 4 weeks with optional researcher support).
Brief digital music-listening task: First session guided by a researcher: Information about the composer's music followed by listening to classical music.
Option to engage in self-administered/guided sessions after the first session.
|
Brief Digital Imagery-competing Task
n=40 Participants
Access to a brief digital imagery-competing task for 24 weeks (first 4 weeks with optional researcher support).
Brief digital imagery-competing task: First session guided by a researcher: A memory cue followed by playing a computer game with mental rotation instructions.
Option to engage in self-administered/guided sessions after the first session.
|
|---|---|---|---|
|
Intention to Leave Job
Week 24
|
10.29 score on a scale
Standard Deviation 4.73
|
9.63 score on a scale
Standard Deviation 4.94
|
10.48 score on a scale
Standard Deviation 3.87
|
|
Intention to Leave Job
Week 4
|
9.71 score on a scale
Standard Deviation 4.51
|
8.58 score on a scale
Standard Deviation 4.99
|
10.58 score on a scale
Standard Deviation 4.11
|
|
Intention to Leave Job
Baseline
|
10.55 score on a scale
Standard Deviation 3.83
|
9.54 score on a scale
Standard Deviation 3.97
|
9.58 score on a scale
Standard Deviation 3.87
|
|
Intention to Leave Job
Week 12
|
11.32 score on a scale
Standard Deviation 3.99
|
10.04 score on a scale
Standard Deviation 4.95
|
10.67 score on a scale
Standard Deviation 4.13
|
SECONDARY outcome
Timeframe: Baseline, 4 weeks, 12 weeks and 24 weeks (all arms)Population: All analyses were completed on an intention-to-treat basis as a between-group comparison.
The 5-level version of the EuroQol-5D (EQ-5D-5L) is a brief, five-item measure for assessing general quality of life and health status. Items assess mobility, self-care, usual activities, pain/discomfort and anxiety/depression each on a 5-point scale. The mobility item is scored on a 5-point ordinal scale from "I have no problems in walking about" to "I am unable to walk about".
Outcome measures
| Measure |
Treatment As Usual
n=20 Participants
Access to routine care that participants would otherwise receive if having intrusive memories of traumatic events for 24 weeks.
Treatment As Usual: Access to routine care that participants would otherwise receive if having intrusive memories of traumatic events.
|
Brief Digital Music-listening Task
n=39 Participants
Access to a brief digital music-listening task for 24 weeks (first 4 weeks with optional researcher support).
Brief digital music-listening task: First session guided by a researcher: Information about the composer's music followed by listening to classical music.
Option to engage in self-administered/guided sessions after the first session.
|
Brief Digital Imagery-competing Task
n=40 Participants
Access to a brief digital imagery-competing task for 24 weeks (first 4 weeks with optional researcher support).
Brief digital imagery-competing task: First session guided by a researcher: A memory cue followed by playing a computer game with mental rotation instructions.
Option to engage in self-administered/guided sessions after the first session.
|
|---|---|---|---|
|
5-level European Quality of Life 5 Dimension (EQ-5D-5L), Mobility
Mobility - Baseline · I have no problems in walking about
|
19 Participants
|
24 Participants
|
31 Participants
|
|
5-level European Quality of Life 5 Dimension (EQ-5D-5L), Mobility
Mobility - Baseline · I have slight problems in walking about
|
1 Participants
|
10 Participants
|
7 Participants
|
|
5-level European Quality of Life 5 Dimension (EQ-5D-5L), Mobility
Mobility - Baseline · I have moderate problems in walking about
|
0 Participants
|
4 Participants
|
1 Participants
|
|
5-level European Quality of Life 5 Dimension (EQ-5D-5L), Mobility
Mobility - Baseline · I have severe problems in walking about
|
0 Participants
|
1 Participants
|
1 Participants
|
|
5-level European Quality of Life 5 Dimension (EQ-5D-5L), Mobility
Mobility - Baseline · I am unable to walk about
|
0 Participants
|
0 Participants
|
0 Participants
|
|
5-level European Quality of Life 5 Dimension (EQ-5D-5L), Mobility
Mobility - Week 4 · I have no problems in walking about
|
15 Participants
|
21 Participants
|
18 Participants
|
|
5-level European Quality of Life 5 Dimension (EQ-5D-5L), Mobility
Mobility - Week 4 · I have slight problems in walking about
|
2 Participants
|
4 Participants
|
3 Participants
|
|
5-level European Quality of Life 5 Dimension (EQ-5D-5L), Mobility
Mobility - Week 4 · I have moderate problems in walking about
|
0 Participants
|
1 Participants
|
3 Participants
|
|
5-level European Quality of Life 5 Dimension (EQ-5D-5L), Mobility
Mobility - Week 4 · I have severe problems in walking about
|
0 Participants
|
0 Participants
|
0 Participants
|
|
5-level European Quality of Life 5 Dimension (EQ-5D-5L), Mobility
Mobility - Week 4 · I am unable to walk about
|
0 Participants
|
0 Participants
|
0 Participants
|
|
5-level European Quality of Life 5 Dimension (EQ-5D-5L), Mobility
Mobility - Week 12 · I have no problems in walking about
|
16 Participants
|
21 Participants
|
17 Participants
|
|
5-level European Quality of Life 5 Dimension (EQ-5D-5L), Mobility
Mobility - Week 12 · I have slight problems in walking about
|
2 Participants
|
3 Participants
|
1 Participants
|
|
5-level European Quality of Life 5 Dimension (EQ-5D-5L), Mobility
Mobility - Week 12 · I have moderate problems in walking about
|
1 Participants
|
0 Participants
|
2 Participants
|
|
5-level European Quality of Life 5 Dimension (EQ-5D-5L), Mobility
Mobility - Week 12 · I have severe problems in walking about
|
0 Participants
|
0 Participants
|
1 Participants
|
|
5-level European Quality of Life 5 Dimension (EQ-5D-5L), Mobility
Mobility - Week 12 · I am unable to walk about
|
0 Participants
|
0 Participants
|
0 Participants
|
|
5-level European Quality of Life 5 Dimension (EQ-5D-5L), Mobility
Mobility - Week 24 · I have no problems in walking about
|
14 Participants
|
19 Participants
|
17 Participants
|
|
5-level European Quality of Life 5 Dimension (EQ-5D-5L), Mobility
Mobility - Week 24 · I have slight problems in walking about
|
2 Participants
|
5 Participants
|
5 Participants
|
|
5-level European Quality of Life 5 Dimension (EQ-5D-5L), Mobility
Mobility - Week 24 · I have moderate problems in walking about
|
0 Participants
|
0 Participants
|
3 Participants
|
|
5-level European Quality of Life 5 Dimension (EQ-5D-5L), Mobility
Mobility - Week 24 · I have severe problems in walking about
|
0 Participants
|
0 Participants
|
0 Participants
|
|
5-level European Quality of Life 5 Dimension (EQ-5D-5L), Mobility
Mobility - Week 24 · I am unable to walk about
|
0 Participants
|
0 Participants
|
0 Participants
|
SECONDARY outcome
Timeframe: Baseline, Week 4, Week 12 and Week 24Population: All analyses were completed on an intention-to-treat basis as a between-group comparison.
The 5-level version of the EuroQol-5D (EQ-5D-5L) is a brief, five-item measure for assessing general quality of life and health status. Items assess mobility, self-care, usual activities, pain/discomfort and anxiety/depression each on a 5-point scale. The self care item is scored on a 5-point ordinal scale from "I have no problems washing or dressing myself" to "I am unable to wash or dress myself".
Outcome measures
| Measure |
Treatment As Usual
n=20 Participants
Access to routine care that participants would otherwise receive if having intrusive memories of traumatic events for 24 weeks.
Treatment As Usual: Access to routine care that participants would otherwise receive if having intrusive memories of traumatic events.
|
Brief Digital Music-listening Task
n=39 Participants
Access to a brief digital music-listening task for 24 weeks (first 4 weeks with optional researcher support).
Brief digital music-listening task: First session guided by a researcher: Information about the composer's music followed by listening to classical music.
Option to engage in self-administered/guided sessions after the first session.
|
Brief Digital Imagery-competing Task
n=40 Participants
Access to a brief digital imagery-competing task for 24 weeks (first 4 weeks with optional researcher support).
Brief digital imagery-competing task: First session guided by a researcher: A memory cue followed by playing a computer game with mental rotation instructions.
Option to engage in self-administered/guided sessions after the first session.
|
|---|---|---|---|
|
5-level European Quality of Life 5 Dimension (EQ-5D-5L), Self Care
Self Care - Week 24 · I have severe problems washing or dressing myself
|
0 Participants
|
0 Participants
|
0 Participants
|
|
5-level European Quality of Life 5 Dimension (EQ-5D-5L), Self Care
Self Care - Week 24 · I am unable to wash or dress myself
|
0 Participants
|
0 Participants
|
0 Participants
|
|
5-level European Quality of Life 5 Dimension (EQ-5D-5L), Self Care
Self Care - Baseline · I have no problems washing or dressing myself
|
18 Participants
|
34 Participants
|
33 Participants
|
|
5-level European Quality of Life 5 Dimension (EQ-5D-5L), Self Care
Self Care - Baseline · I have slight problems washing or dressing myself
|
1 Participants
|
4 Participants
|
3 Participants
|
|
5-level European Quality of Life 5 Dimension (EQ-5D-5L), Self Care
Self Care - Baseline · I have moderate problems washing or dressing myself
|
1 Participants
|
0 Participants
|
3 Participants
|
|
5-level European Quality of Life 5 Dimension (EQ-5D-5L), Self Care
Self Care - Baseline · I have severe problems washing or dressing myself
|
0 Participants
|
1 Participants
|
1 Participants
|
|
5-level European Quality of Life 5 Dimension (EQ-5D-5L), Self Care
Self Care - Baseline · I am unable to wash or dress myself
|
0 Participants
|
0 Participants
|
0 Participants
|
|
5-level European Quality of Life 5 Dimension (EQ-5D-5L), Self Care
Self Care - Week 4 · I have no problems washing or dressing myself
|
15 Participants
|
21 Participants
|
20 Participants
|
|
5-level European Quality of Life 5 Dimension (EQ-5D-5L), Self Care
Self Care - Week 4 · I have slight problems washing or dressing myself
|
1 Participants
|
5 Participants
|
3 Participants
|
|
5-level European Quality of Life 5 Dimension (EQ-5D-5L), Self Care
Self Care - Week 4 · I have moderate problems washing or dressing myself
|
1 Participants
|
0 Participants
|
1 Participants
|
|
5-level European Quality of Life 5 Dimension (EQ-5D-5L), Self Care
Self Care - Week 4 · I have severe problems washing or dressing myself
|
0 Participants
|
0 Participants
|
0 Participants
|
|
5-level European Quality of Life 5 Dimension (EQ-5D-5L), Self Care
Self Care - Week 4 · I am unable to wash or dress myself
|
0 Participants
|
0 Participants
|
0 Participants
|
|
5-level European Quality of Life 5 Dimension (EQ-5D-5L), Self Care
Self Care - Week 12 · I have no problems washing or dressing myself
|
17 Participants
|
24 Participants
|
17 Participants
|
|
5-level European Quality of Life 5 Dimension (EQ-5D-5L), Self Care
Self Care - Week 12 · I have slight problems washing or dressing myself
|
1 Participants
|
0 Participants
|
3 Participants
|
|
5-level European Quality of Life 5 Dimension (EQ-5D-5L), Self Care
Self Care - Week 12 · I have moderate problems washing or dressing myself
|
0 Participants
|
0 Participants
|
0 Participants
|
|
5-level European Quality of Life 5 Dimension (EQ-5D-5L), Self Care
Self Care - Week 12 · I have severe problems washing or dressing myself
|
1 Participants
|
0 Participants
|
1 Participants
|
|
5-level European Quality of Life 5 Dimension (EQ-5D-5L), Self Care
Self Care - Week 12 · I am unable to wash or dress myself
|
0 Participants
|
0 Participants
|
0 Participants
|
|
5-level European Quality of Life 5 Dimension (EQ-5D-5L), Self Care
Self Care - Week 24 · I have no problems washing or dressing myself
|
14 Participants
|
22 Participants
|
21 Participants
|
|
5-level European Quality of Life 5 Dimension (EQ-5D-5L), Self Care
Self Care - Week 24 · I have slight problems washing or dressing myself
|
1 Participants
|
2 Participants
|
4 Participants
|
|
5-level European Quality of Life 5 Dimension (EQ-5D-5L), Self Care
Self Care - Week 24 · I have moderate problems washing or dressing myself
|
1 Participants
|
0 Participants
|
0 Participants
|
SECONDARY outcome
Timeframe: Baseline, Week 4, Week 12 and Week 24Population: All analyses were completed on an intention-to-treat basis as a between-group comparison.
The 5-level version of the EuroQol-5D (EQ-5D-5L) is a brief, five-item measure for assessing general quality of life and health status. Items assess mobility, self-care, usual activities, pain/discomfort and anxiety/depression each on a 5-point scale. The usual activities item is scored on a 5-point ordinal scale from "I have no problems doing my usual activities" to "I am unable to do my usual activities".
Outcome measures
| Measure |
Treatment As Usual
n=20 Participants
Access to routine care that participants would otherwise receive if having intrusive memories of traumatic events for 24 weeks.
Treatment As Usual: Access to routine care that participants would otherwise receive if having intrusive memories of traumatic events.
|
Brief Digital Music-listening Task
n=39 Participants
Access to a brief digital music-listening task for 24 weeks (first 4 weeks with optional researcher support).
Brief digital music-listening task: First session guided by a researcher: Information about the composer's music followed by listening to classical music.
Option to engage in self-administered/guided sessions after the first session.
|
Brief Digital Imagery-competing Task
n=40 Participants
Access to a brief digital imagery-competing task for 24 weeks (first 4 weeks with optional researcher support).
Brief digital imagery-competing task: First session guided by a researcher: A memory cue followed by playing a computer game with mental rotation instructions.
Option to engage in self-administered/guided sessions after the first session.
|
|---|---|---|---|
|
5-level European Quality of Life 5 Dimension (EQ-5D-5L), Usual Activities
Usual Activities - Baseline · I have no problems doing my usual activities
|
13 Participants
|
19 Participants
|
21 Participants
|
|
5-level European Quality of Life 5 Dimension (EQ-5D-5L), Usual Activities
Usual Activities - Baseline · I have slight problems doing my usual activities
|
7 Participants
|
12 Participants
|
11 Participants
|
|
5-level European Quality of Life 5 Dimension (EQ-5D-5L), Usual Activities
Usual Activities - Baseline · I have moderate problems doing my usual activities
|
0 Participants
|
7 Participants
|
5 Participants
|
|
5-level European Quality of Life 5 Dimension (EQ-5D-5L), Usual Activities
Usual Activities - Baseline · I have severe problems doing my usual activities
|
0 Participants
|
1 Participants
|
3 Participants
|
|
5-level European Quality of Life 5 Dimension (EQ-5D-5L), Usual Activities
Usual Activities - Baseline · I am unable to do my usual activities
|
0 Participants
|
0 Participants
|
0 Participants
|
|
5-level European Quality of Life 5 Dimension (EQ-5D-5L), Usual Activities
Usual Activities - Week 4 · I have no problems doing my usual activities
|
10 Participants
|
19 Participants
|
16 Participants
|
|
5-level European Quality of Life 5 Dimension (EQ-5D-5L), Usual Activities
Usual Activities - Week 4 · I have slight problems doing my usual activities
|
7 Participants
|
3 Participants
|
2 Participants
|
|
5-level European Quality of Life 5 Dimension (EQ-5D-5L), Usual Activities
Usual Activities - Week 4 · I have moderate problems doing my usual activities
|
0 Participants
|
3 Participants
|
6 Participants
|
|
5-level European Quality of Life 5 Dimension (EQ-5D-5L), Usual Activities
Usual Activities - Week 4 · I have severe problems doing my usual activities
|
0 Participants
|
0 Participants
|
0 Participants
|
|
5-level European Quality of Life 5 Dimension (EQ-5D-5L), Usual Activities
Usual Activities - Week 4 · I am unable to do my usual activities
|
0 Participants
|
1 Participants
|
0 Participants
|
|
5-level European Quality of Life 5 Dimension (EQ-5D-5L), Usual Activities
Usual Activities - Week 12 · I have no problems doing my usual activities
|
15 Participants
|
19 Participants
|
13 Participants
|
|
5-level European Quality of Life 5 Dimension (EQ-5D-5L), Usual Activities
Usual Activities - Week 12 · I have slight problems doing my usual activities
|
3 Participants
|
4 Participants
|
5 Participants
|
|
5-level European Quality of Life 5 Dimension (EQ-5D-5L), Usual Activities
Usual Activities - Week 12 · I have moderate problems doing my usual activities
|
1 Participants
|
1 Participants
|
3 Participants
|
|
5-level European Quality of Life 5 Dimension (EQ-5D-5L), Usual Activities
Usual Activities - Week 12 · I have severe problems doing my usual activities
|
0 Participants
|
0 Participants
|
0 Participants
|
|
5-level European Quality of Life 5 Dimension (EQ-5D-5L), Usual Activities
Usual Activities - Week 12 · I am unable to do my usual activities
|
0 Participants
|
0 Participants
|
0 Participants
|
|
5-level European Quality of Life 5 Dimension (EQ-5D-5L), Usual Activities
Usual Activities - Week 24 · I have no problems doing my usual activities
|
10 Participants
|
16 Participants
|
16 Participants
|
|
5-level European Quality of Life 5 Dimension (EQ-5D-5L), Usual Activities
Usual Activities - Week 24 · I have slight problems doing my usual activities
|
4 Participants
|
6 Participants
|
5 Participants
|
|
5-level European Quality of Life 5 Dimension (EQ-5D-5L), Usual Activities
Usual Activities - Week 24 · I have moderate problems doing my usual activities
|
2 Participants
|
1 Participants
|
4 Participants
|
|
5-level European Quality of Life 5 Dimension (EQ-5D-5L), Usual Activities
Usual Activities - Week 24 · I have severe problems doing my usual activities
|
0 Participants
|
1 Participants
|
0 Participants
|
|
5-level European Quality of Life 5 Dimension (EQ-5D-5L), Usual Activities
Usual Activities - Week 24 · I am unable to do my usual activities
|
0 Participants
|
0 Participants
|
0 Participants
|
SECONDARY outcome
Timeframe: Baseline, Week 4, Week 12 and Week 24Population: All analyses were completed on an intention-to-treat basis as a between-group comparison.
The 5-level version of the EuroQol-5D (EQ-5D-5L) is a brief, five-item measure for assessing general quality of life and health status. Items assess mobility, self-care, usual activities, pain/discomfort and anxiety/depression each on a 5-point scale. The pain / discomfort item is scored on a 5-point ordinal scale from "I have no pain or discomfort" to "I have extreme pain or discomfort".
Outcome measures
| Measure |
Treatment As Usual
n=20 Participants
Access to routine care that participants would otherwise receive if having intrusive memories of traumatic events for 24 weeks.
Treatment As Usual: Access to routine care that participants would otherwise receive if having intrusive memories of traumatic events.
|
Brief Digital Music-listening Task
n=39 Participants
Access to a brief digital music-listening task for 24 weeks (first 4 weeks with optional researcher support).
Brief digital music-listening task: First session guided by a researcher: Information about the composer's music followed by listening to classical music.
Option to engage in self-administered/guided sessions after the first session.
|
Brief Digital Imagery-competing Task
n=40 Participants
Access to a brief digital imagery-competing task for 24 weeks (first 4 weeks with optional researcher support).
Brief digital imagery-competing task: First session guided by a researcher: A memory cue followed by playing a computer game with mental rotation instructions.
Option to engage in self-administered/guided sessions after the first session.
|
|---|---|---|---|
|
5-level European Quality of Life 5 Dimension (EQ-5D-5L), Pain / Discomfort
Pain / Discomfort - Baseline · I have slight pain or discomfort
|
8 Participants
|
11 Participants
|
17 Participants
|
|
5-level European Quality of Life 5 Dimension (EQ-5D-5L), Pain / Discomfort
Pain / Discomfort - Baseline · I have no pain or discomfort
|
9 Participants
|
16 Participants
|
12 Participants
|
|
5-level European Quality of Life 5 Dimension (EQ-5D-5L), Pain / Discomfort
Pain / Discomfort - Baseline · I have moderate pain or discomfort
|
3 Participants
|
8 Participants
|
6 Participants
|
|
5-level European Quality of Life 5 Dimension (EQ-5D-5L), Pain / Discomfort
Pain / Discomfort - Baseline · I have severe pain or discomfort
|
0 Participants
|
1 Participants
|
3 Participants
|
|
5-level European Quality of Life 5 Dimension (EQ-5D-5L), Pain / Discomfort
Pain / Discomfort - Baseline · I have extreme pain or discomfort
|
0 Participants
|
3 Participants
|
2 Participants
|
|
5-level European Quality of Life 5 Dimension (EQ-5D-5L), Pain / Discomfort
Pain / Discomfort - Week 4 · I have no pain or discomfort
|
7 Participants
|
9 Participants
|
11 Participants
|
|
5-level European Quality of Life 5 Dimension (EQ-5D-5L), Pain / Discomfort
Pain / Discomfort - Week 4 · I have slight pain or discomfort
|
7 Participants
|
12 Participants
|
5 Participants
|
|
5-level European Quality of Life 5 Dimension (EQ-5D-5L), Pain / Discomfort
Pain / Discomfort - Week 4 · I have moderate pain or discomfort
|
3 Participants
|
3 Participants
|
2 Participants
|
|
5-level European Quality of Life 5 Dimension (EQ-5D-5L), Pain / Discomfort
Pain / Discomfort - Week 4 · I have severe pain or discomfort
|
0 Participants
|
1 Participants
|
6 Participants
|
|
5-level European Quality of Life 5 Dimension (EQ-5D-5L), Pain / Discomfort
Pain / Discomfort - Week 4 · I have extreme pain or discomfort
|
0 Participants
|
1 Participants
|
0 Participants
|
|
5-level European Quality of Life 5 Dimension (EQ-5D-5L), Pain / Discomfort
Pain / Discomfort - Week 12 · I have no pain or discomfort
|
9 Participants
|
8 Participants
|
9 Participants
|
|
5-level European Quality of Life 5 Dimension (EQ-5D-5L), Pain / Discomfort
Pain / Discomfort - Week 12 · I have slight pain or discomfort
|
8 Participants
|
11 Participants
|
5 Participants
|
|
5-level European Quality of Life 5 Dimension (EQ-5D-5L), Pain / Discomfort
Pain / Discomfort - Week 12 · I have moderate pain or discomfort
|
2 Participants
|
4 Participants
|
5 Participants
|
|
5-level European Quality of Life 5 Dimension (EQ-5D-5L), Pain / Discomfort
Pain / Discomfort - Week 12 · I have severe pain or discomfort
|
0 Participants
|
1 Participants
|
2 Participants
|
|
5-level European Quality of Life 5 Dimension (EQ-5D-5L), Pain / Discomfort
Pain / Discomfort - Week 12 · I have extreme pain or discomfort
|
0 Participants
|
0 Participants
|
0 Participants
|
|
5-level European Quality of Life 5 Dimension (EQ-5D-5L), Pain / Discomfort
Pain / Discomfort - Week 24 · I have no pain or discomfort
|
9 Participants
|
10 Participants
|
11 Participants
|
|
5-level European Quality of Life 5 Dimension (EQ-5D-5L), Pain / Discomfort
Pain / Discomfort - Week 24 · I have slight pain or discomfort
|
4 Participants
|
8 Participants
|
6 Participants
|
|
5-level European Quality of Life 5 Dimension (EQ-5D-5L), Pain / Discomfort
Pain / Discomfort - Week 24 · I have moderate pain or discomfort
|
3 Participants
|
5 Participants
|
5 Participants
|
|
5-level European Quality of Life 5 Dimension (EQ-5D-5L), Pain / Discomfort
Pain / Discomfort - Week 24 · I have severe pain or discomfort
|
0 Participants
|
1 Participants
|
2 Participants
|
|
5-level European Quality of Life 5 Dimension (EQ-5D-5L), Pain / Discomfort
Pain / Discomfort - Week 24 · I have extreme pain or discomfort
|
0 Participants
|
0 Participants
|
1 Participants
|
SECONDARY outcome
Timeframe: Baseline, Week 4, Week 12 and Week 24Population: All analyses were completed on an intention-to-treat basis as a between-group comparison.
The 5-level version of the EuroQol-5D (EQ-5D-5L) is a brief, five-item measure for assessing general quality of life and health status. Items assess mobility, self-care, usual activities, pain/discomfort and anxiety/depression each on a 5-point scale. The anxiety / depression item is scored on a 5-point ordinal scale from "I am not anxious or depressed" to "I am extremely anxious or depressed".
Outcome measures
| Measure |
Treatment As Usual
n=20 Participants
Access to routine care that participants would otherwise receive if having intrusive memories of traumatic events for 24 weeks.
Treatment As Usual: Access to routine care that participants would otherwise receive if having intrusive memories of traumatic events.
|
Brief Digital Music-listening Task
n=39 Participants
Access to a brief digital music-listening task for 24 weeks (first 4 weeks with optional researcher support).
Brief digital music-listening task: First session guided by a researcher: Information about the composer's music followed by listening to classical music.
Option to engage in self-administered/guided sessions after the first session.
|
Brief Digital Imagery-competing Task
n=40 Participants
Access to a brief digital imagery-competing task for 24 weeks (first 4 weeks with optional researcher support).
Brief digital imagery-competing task: First session guided by a researcher: A memory cue followed by playing a computer game with mental rotation instructions.
Option to engage in self-administered/guided sessions after the first session.
|
|---|---|---|---|
|
5-level European Quality of Life 5 Dimension (EQ-5D-5L), Anxiety / Depression
Anxiety / Depression - Week 24 · I am slightly anxious or depressed
|
7 Participants
|
9 Participants
|
12 Participants
|
|
5-level European Quality of Life 5 Dimension (EQ-5D-5L), Anxiety / Depression
Anxiety / Depression - Baseline · I am not anxious or depressed
|
3 Participants
|
7 Participants
|
6 Participants
|
|
5-level European Quality of Life 5 Dimension (EQ-5D-5L), Anxiety / Depression
Anxiety / Depression - Baseline · I am slightly anxious or depressed
|
8 Participants
|
17 Participants
|
15 Participants
|
|
5-level European Quality of Life 5 Dimension (EQ-5D-5L), Anxiety / Depression
Anxiety / Depression - Baseline · I am moderately anxious or depressed
|
5 Participants
|
11 Participants
|
14 Participants
|
|
5-level European Quality of Life 5 Dimension (EQ-5D-5L), Anxiety / Depression
Anxiety / Depression - Baseline · I am severely anxious or depressed
|
3 Participants
|
4 Participants
|
4 Participants
|
|
5-level European Quality of Life 5 Dimension (EQ-5D-5L), Anxiety / Depression
Anxiety / Depression - Baseline · I am extremely anxious or depressed
|
1 Participants
|
0 Participants
|
1 Participants
|
|
5-level European Quality of Life 5 Dimension (EQ-5D-5L), Anxiety / Depression
Anxiety / Depression - Week 4 · I am not anxious or depressed
|
2 Participants
|
8 Participants
|
8 Participants
|
|
5-level European Quality of Life 5 Dimension (EQ-5D-5L), Anxiety / Depression
Anxiety / Depression - Week 4 · I am slightly anxious or depressed
|
6 Participants
|
10 Participants
|
12 Participants
|
|
5-level European Quality of Life 5 Dimension (EQ-5D-5L), Anxiety / Depression
Anxiety / Depression - Week 24 · I am moderately anxious or depressed
|
4 Participants
|
4 Participants
|
3 Participants
|
|
5-level European Quality of Life 5 Dimension (EQ-5D-5L), Anxiety / Depression
Anxiety / Depression - Week 4 · I am moderately anxious or depressed
|
8 Participants
|
5 Participants
|
4 Participants
|
|
5-level European Quality of Life 5 Dimension (EQ-5D-5L), Anxiety / Depression
Anxiety / Depression - Week 24 · I am severely anxious or depressed
|
2 Participants
|
1 Participants
|
1 Participants
|
|
5-level European Quality of Life 5 Dimension (EQ-5D-5L), Anxiety / Depression
Anxiety / Depression - Week 24 · I am extremely anxious or depressed
|
0 Participants
|
0 Participants
|
0 Participants
|
|
5-level European Quality of Life 5 Dimension (EQ-5D-5L), Anxiety / Depression
Anxiety / Depression - Week 4 · I am severely anxious or depressed
|
1 Participants
|
3 Participants
|
0 Participants
|
|
5-level European Quality of Life 5 Dimension (EQ-5D-5L), Anxiety / Depression
Anxiety / Depression - Week 4 · I am extremely anxious or depressed
|
0 Participants
|
0 Participants
|
0 Participants
|
|
5-level European Quality of Life 5 Dimension (EQ-5D-5L), Anxiety / Depression
Anxiety / Depression - Week 12 · I am not anxious or depressed
|
4 Participants
|
7 Participants
|
6 Participants
|
|
5-level European Quality of Life 5 Dimension (EQ-5D-5L), Anxiety / Depression
Anxiety / Depression - Week 12 · I am slightly anxious or depressed
|
8 Participants
|
11 Participants
|
11 Participants
|
|
5-level European Quality of Life 5 Dimension (EQ-5D-5L), Anxiety / Depression
Anxiety / Depression - Week 12 · I am moderately anxious or depressed
|
6 Participants
|
6 Participants
|
4 Participants
|
|
5-level European Quality of Life 5 Dimension (EQ-5D-5L), Anxiety / Depression
Anxiety / Depression - Week 12 · I am severely anxious or depressed
|
1 Participants
|
0 Participants
|
0 Participants
|
|
5-level European Quality of Life 5 Dimension (EQ-5D-5L), Anxiety / Depression
Anxiety / Depression - Week 12 · I am extremely anxious or depressed
|
0 Participants
|
0 Participants
|
0 Participants
|
|
5-level European Quality of Life 5 Dimension (EQ-5D-5L), Anxiety / Depression
Anxiety / Depression - Week 24 · I am not anxious or depressed
|
3 Participants
|
10 Participants
|
9 Participants
|
SECONDARY outcome
Timeframe: Baseline, Week 4, Week 12 and Week 24Population: All analyses were completed on an intention-to-treat basis as a between-group comparison.
The 5-level version of the EuroQol-5D (EQ-5D-5L) is a brief measure for assessing general quality of life and health status. Respondents rate their overall health today on a visual analogue scale from 0 (the worst health you can imagine) to 100 (the best health you can imagine).
Outcome measures
| Measure |
Treatment As Usual
n=20 Participants
Access to routine care that participants would otherwise receive if having intrusive memories of traumatic events for 24 weeks.
Treatment As Usual: Access to routine care that participants would otherwise receive if having intrusive memories of traumatic events.
|
Brief Digital Music-listening Task
n=39 Participants
Access to a brief digital music-listening task for 24 weeks (first 4 weeks with optional researcher support).
Brief digital music-listening task: First session guided by a researcher: Information about the composer's music followed by listening to classical music.
Option to engage in self-administered/guided sessions after the first session.
|
Brief Digital Imagery-competing Task
n=40 Participants
Access to a brief digital imagery-competing task for 24 weeks (first 4 weeks with optional researcher support).
Brief digital imagery-competing task: First session guided by a researcher: A memory cue followed by playing a computer game with mental rotation instructions.
Option to engage in self-administered/guided sessions after the first session.
|
|---|---|---|---|
|
5-level European Quality of Life 5 Dimension (EQ-5D-5L), Overall Health
Baseline
|
70.80 score on a scale
Standard Deviation 14.11
|
71.79 score on a scale
Standard Deviation 16.81
|
66.40 score on a scale
Standard Deviation 17.72
|
|
5-level European Quality of Life 5 Dimension (EQ-5D-5L), Overall Health
Week 4
|
74.53 score on a scale
Standard Deviation 16.42
|
70.08 score on a scale
Standard Deviation 20.10
|
73.04 score on a scale
Standard Deviation 18.18
|
|
5-level European Quality of Life 5 Dimension (EQ-5D-5L), Overall Health
Week 12
|
75.21 score on a scale
Standard Deviation 17.49
|
75.17 score on a scale
Standard Deviation 19.76
|
72.95 score on a scale
Standard Deviation 17.05
|
|
5-level European Quality of Life 5 Dimension (EQ-5D-5L), Overall Health
Week 24
|
71.63 score on a scale
Standard Deviation 17.63
|
75.75 score on a scale
Standard Deviation 20.69
|
73.84 score on a scale
Standard Deviation 18.67
|
SECONDARY outcome
Timeframe: Baseline, 4 weeks, 12 weeks and 24 weeks (all arms)Population: All analyses were completed on an intention-to-treat basis as a between-group comparison.
The 12-item, self-report version of the WHODAS 2.0 will be used to assess difficulties in relation to the impact of intrusive memories. Respondents rate how much difficulty they have had in each area in the past 30 days, from 0 (none) to 4 (extreme or cannot do). The overall score is calculated as a percentage of the maximum possible score (i.e., 48 points), with greater scores indicating greater impairment.
Outcome measures
| Measure |
Treatment As Usual
n=20 Participants
Access to routine care that participants would otherwise receive if having intrusive memories of traumatic events for 24 weeks.
Treatment As Usual: Access to routine care that participants would otherwise receive if having intrusive memories of traumatic events.
|
Brief Digital Music-listening Task
n=39 Participants
Access to a brief digital music-listening task for 24 weeks (first 4 weeks with optional researcher support).
Brief digital music-listening task: First session guided by a researcher: Information about the composer's music followed by listening to classical music.
Option to engage in self-administered/guided sessions after the first session.
|
Brief Digital Imagery-competing Task
n=40 Participants
Access to a brief digital imagery-competing task for 24 weeks (first 4 weeks with optional researcher support).
Brief digital imagery-competing task: First session guided by a researcher: A memory cue followed by playing a computer game with mental rotation instructions.
Option to engage in self-administered/guided sessions after the first session.
|
|---|---|---|---|
|
World Health Organization Disability Assessment Schedule 12-item Version (WHODAS 2.0)
Baseline
|
15.63 score on a scale
Standard Deviation 10.70
|
21.37 score on a scale
Standard Deviation 14.88
|
23.55 score on a scale
Standard Deviation 17.48
|
|
World Health Organization Disability Assessment Schedule 12-item Version (WHODAS 2.0)
Week 12
|
18.09 score on a scale
Standard Deviation 16.74
|
13.29 score on a scale
Standard Deviation 11.42
|
15.97 score on a scale
Standard Deviation 17.09
|
|
World Health Organization Disability Assessment Schedule 12-item Version (WHODAS 2.0)
Week 4
|
16.42 score on a scale
Standard Deviation 10.62
|
18.27 score on a scale
Standard Deviation 15.06
|
15.02 score on a scale
Standard Deviation 14.55
|
|
World Health Organization Disability Assessment Schedule 12-item Version (WHODAS 2.0)
Week 24
|
18.36 score on a scale
Standard Deviation 15.63
|
14.50 score on a scale
Standard Deviation 16.57
|
13.25 score on a scale
Standard Deviation 14.37
|
SECONDARY outcome
Timeframe: Baseline, 4 weeks, 12 weeks and 24 weeks (all arms)Population: All analyses were completed on an intention-to-treat basis as a between-group comparison.
This questionnaire assesses a number of intrusive memories characteristics, including frequency (Item 1: 7-point categorical response from 'never' to 'many times a day'); distress (Item 2: 0=not at all to 10=extremely); disruption to concentration (Item 3: 0=not at all to 10=extremely); interference (Item 4: how much (0=not at all to 10=extremely), and Item 4a: for how long (6-point response from '\<1min' to '\>60mins')); impact on work functioning (Item 5: how much (0=not at all to 10=extremely) and Item 6: in what ways (open text response)); impact on functioning in other areas of life (Item 7: how much (0=not at all to 10=extremely) and in what ways (Item 8: open text response)). Here we present Item 1 assessing the frequency of intrusive memories on a 7-point scale from 'never' to 'many times a day'. Other items from this questionnaire are presented below.
Outcome measures
| Measure |
Treatment As Usual
n=20 Participants
Access to routine care that participants would otherwise receive if having intrusive memories of traumatic events for 24 weeks.
Treatment As Usual: Access to routine care that participants would otherwise receive if having intrusive memories of traumatic events.
|
Brief Digital Music-listening Task
n=39 Participants
Access to a brief digital music-listening task for 24 weeks (first 4 weeks with optional researcher support).
Brief digital music-listening task: First session guided by a researcher: Information about the composer's music followed by listening to classical music.
Option to engage in self-administered/guided sessions after the first session.
|
Brief Digital Imagery-competing Task
n=40 Participants
Access to a brief digital imagery-competing task for 24 weeks (first 4 weeks with optional researcher support).
Brief digital imagery-competing task: First session guided by a researcher: A memory cue followed by playing a computer game with mental rotation instructions.
Option to engage in self-administered/guided sessions after the first session.
|
|---|---|---|---|
|
Intrusive Memory Ratings: Item 1. Approximately How Often Did Intrusive Memories of the Traumatic Event Pop Into Your Mind?
Baseline · Never
|
0 Participants
|
0 Participants
|
0 Participants
|
|
Intrusive Memory Ratings: Item 1. Approximately How Often Did Intrusive Memories of the Traumatic Event Pop Into Your Mind?
Baseline · Once
|
1 Participants
|
0 Participants
|
0 Participants
|
|
Intrusive Memory Ratings: Item 1. Approximately How Often Did Intrusive Memories of the Traumatic Event Pop Into Your Mind?
Baseline · Twice
|
1 Participants
|
2 Participants
|
1 Participants
|
|
Intrusive Memory Ratings: Item 1. Approximately How Often Did Intrusive Memories of the Traumatic Event Pop Into Your Mind?
Baseline · Every other day
|
8 Participants
|
12 Participants
|
11 Participants
|
|
Intrusive Memory Ratings: Item 1. Approximately How Often Did Intrusive Memories of the Traumatic Event Pop Into Your Mind?
Baseline · Once a day
|
4 Participants
|
5 Participants
|
4 Participants
|
|
Intrusive Memory Ratings: Item 1. Approximately How Often Did Intrusive Memories of the Traumatic Event Pop Into Your Mind?
Baseline · Several times a day
|
3 Participants
|
20 Participants
|
23 Participants
|
|
Intrusive Memory Ratings: Item 1. Approximately How Often Did Intrusive Memories of the Traumatic Event Pop Into Your Mind?
Baseline · Many times a day
|
3 Participants
|
0 Participants
|
1 Participants
|
|
Intrusive Memory Ratings: Item 1. Approximately How Often Did Intrusive Memories of the Traumatic Event Pop Into Your Mind?
Week 4 · Never
|
0 Participants
|
1 Participants
|
4 Participants
|
|
Intrusive Memory Ratings: Item 1. Approximately How Often Did Intrusive Memories of the Traumatic Event Pop Into Your Mind?
Week 4 · Once
|
2 Participants
|
2 Participants
|
4 Participants
|
|
Intrusive Memory Ratings: Item 1. Approximately How Often Did Intrusive Memories of the Traumatic Event Pop Into Your Mind?
Week 4 · Twice
|
2 Participants
|
2 Participants
|
8 Participants
|
|
Intrusive Memory Ratings: Item 1. Approximately How Often Did Intrusive Memories of the Traumatic Event Pop Into Your Mind?
Week 4 · Every other day
|
7 Participants
|
12 Participants
|
3 Participants
|
|
Intrusive Memory Ratings: Item 1. Approximately How Often Did Intrusive Memories of the Traumatic Event Pop Into Your Mind?
Week 4 · Once a day
|
3 Participants
|
4 Participants
|
2 Participants
|
|
Intrusive Memory Ratings: Item 1. Approximately How Often Did Intrusive Memories of the Traumatic Event Pop Into Your Mind?
Week 4 · Several times a day
|
3 Participants
|
7 Participants
|
4 Participants
|
|
Intrusive Memory Ratings: Item 1. Approximately How Often Did Intrusive Memories of the Traumatic Event Pop Into Your Mind?
Week 4 · Many times a day
|
1 Participants
|
1 Participants
|
0 Participants
|
|
Intrusive Memory Ratings: Item 1. Approximately How Often Did Intrusive Memories of the Traumatic Event Pop Into Your Mind?
Week 12 · Never
|
4 Participants
|
5 Participants
|
11 Participants
|
|
Intrusive Memory Ratings: Item 1. Approximately How Often Did Intrusive Memories of the Traumatic Event Pop Into Your Mind?
Week 12 · Once
|
5 Participants
|
1 Participants
|
2 Participants
|
|
Intrusive Memory Ratings: Item 1. Approximately How Often Did Intrusive Memories of the Traumatic Event Pop Into Your Mind?
Week 12 · Twice
|
4 Participants
|
3 Participants
|
4 Participants
|
|
Intrusive Memory Ratings: Item 1. Approximately How Often Did Intrusive Memories of the Traumatic Event Pop Into Your Mind?
Week 12 · Every other day
|
1 Participants
|
7 Participants
|
3 Participants
|
|
Intrusive Memory Ratings: Item 1. Approximately How Often Did Intrusive Memories of the Traumatic Event Pop Into Your Mind?
Week 12 · Once a day
|
3 Participants
|
1 Participants
|
1 Participants
|
|
Intrusive Memory Ratings: Item 1. Approximately How Often Did Intrusive Memories of the Traumatic Event Pop Into Your Mind?
Week 12 · Several times a day
|
2 Participants
|
7 Participants
|
0 Participants
|
|
Intrusive Memory Ratings: Item 1. Approximately How Often Did Intrusive Memories of the Traumatic Event Pop Into Your Mind?
Week 12 · Many times a day
|
0 Participants
|
0 Participants
|
0 Participants
|
|
Intrusive Memory Ratings: Item 1. Approximately How Often Did Intrusive Memories of the Traumatic Event Pop Into Your Mind?
Week 24 · Never
|
4 Participants
|
1 Participants
|
14 Participants
|
|
Intrusive Memory Ratings: Item 1. Approximately How Often Did Intrusive Memories of the Traumatic Event Pop Into Your Mind?
Week 24 · Once
|
1 Participants
|
4 Participants
|
6 Participants
|
|
Intrusive Memory Ratings: Item 1. Approximately How Often Did Intrusive Memories of the Traumatic Event Pop Into Your Mind?
Week 24 · Twice
|
7 Participants
|
6 Participants
|
4 Participants
|
|
Intrusive Memory Ratings: Item 1. Approximately How Often Did Intrusive Memories of the Traumatic Event Pop Into Your Mind?
Week 24 · Every other day
|
2 Participants
|
11 Participants
|
2 Participants
|
|
Intrusive Memory Ratings: Item 1. Approximately How Often Did Intrusive Memories of the Traumatic Event Pop Into Your Mind?
Week 24 · Once a day
|
0 Participants
|
0 Participants
|
0 Participants
|
|
Intrusive Memory Ratings: Item 1. Approximately How Often Did Intrusive Memories of the Traumatic Event Pop Into Your Mind?
Week 24 · Several times a day
|
4 Participants
|
1 Participants
|
0 Participants
|
|
Intrusive Memory Ratings: Item 1. Approximately How Often Did Intrusive Memories of the Traumatic Event Pop Into Your Mind?
Week 24 · Many times a day
|
0 Participants
|
1 Participants
|
0 Participants
|
SECONDARY outcome
Timeframe: Baseline, Week 4, Week 12 and Week 24 (all arms)Population: All analyses were completed on an intention-to-treat basis as a between-group comparison.
This questionnaire assesses a number of intrusive memories characteristics, including frequency (Item 1: 7-point categorical response from 'never' to 'many times a day'); distress (Item 2: 0=not at all to 10=extremely); disruption to concentration (Item 3: 0=not at all to 10=extremely); interference (Item 4: how much (0=not at all to 10=extremely), and Item 4a: for how long (6-point response from '\<1min' to '\>60mins')); impact on work functioning (Item 5: how much (0=not at all to 10=extremely) and Item 6: in what ways (open text response)); impact on functioning in other areas of life (Item 7: how much (0=not at all to 10=extremely) and in what ways (Item 8: open text response)). Here we present Item 4a assessing the for how long intrusive memories interfered with what participants were doing on a 7-point scale from '\<1 min' to '\>60 mins'. Other items from this questionnaire are presented below.
Outcome measures
| Measure |
Treatment As Usual
n=20 Participants
Access to routine care that participants would otherwise receive if having intrusive memories of traumatic events for 24 weeks.
Treatment As Usual: Access to routine care that participants would otherwise receive if having intrusive memories of traumatic events.
|
Brief Digital Music-listening Task
n=39 Participants
Access to a brief digital music-listening task for 24 weeks (first 4 weeks with optional researcher support).
Brief digital music-listening task: First session guided by a researcher: Information about the composer's music followed by listening to classical music.
Option to engage in self-administered/guided sessions after the first session.
|
Brief Digital Imagery-competing Task
n=40 Participants
Access to a brief digital imagery-competing task for 24 weeks (first 4 weeks with optional researcher support).
Brief digital imagery-competing task: First session guided by a researcher: A memory cue followed by playing a computer game with mental rotation instructions.
Option to engage in self-administered/guided sessions after the first session.
|
|---|---|---|---|
|
Intrusive Memory Ratings: Item 4a. Duration of Interference
Baseline · <1 min
|
11 Participants
|
12 Participants
|
20 Participants
|
|
Intrusive Memory Ratings: Item 4a. Duration of Interference
Baseline · 1-5 mins
|
8 Participants
|
24 Participants
|
15 Participants
|
|
Intrusive Memory Ratings: Item 4a. Duration of Interference
Baseline · 6-10 mins
|
1 Participants
|
3 Participants
|
5 Participants
|
|
Intrusive Memory Ratings: Item 4a. Duration of Interference
Baseline · 11-30 mins
|
0 Participants
|
0 Participants
|
0 Participants
|
|
Intrusive Memory Ratings: Item 4a. Duration of Interference
Baseline · 31-60 mins
|
0 Participants
|
0 Participants
|
0 Participants
|
|
Intrusive Memory Ratings: Item 4a. Duration of Interference
Baseline · >60 mins
|
0 Participants
|
0 Participants
|
0 Participants
|
|
Intrusive Memory Ratings: Item 4a. Duration of Interference
Week 4 · <1 min
|
10 Participants
|
10 Participants
|
16 Participants
|
|
Intrusive Memory Ratings: Item 4a. Duration of Interference
Week 4 · 1-5 mins
|
8 Participants
|
14 Participants
|
8 Participants
|
|
Intrusive Memory Ratings: Item 4a. Duration of Interference
Week 4 · 6-10 mins
|
0 Participants
|
3 Participants
|
1 Participants
|
|
Intrusive Memory Ratings: Item 4a. Duration of Interference
Week 4 · 11-30 mins
|
0 Participants
|
2 Participants
|
0 Participants
|
|
Intrusive Memory Ratings: Item 4a. Duration of Interference
Week 4 · 31-60 mins
|
0 Participants
|
0 Participants
|
0 Participants
|
|
Intrusive Memory Ratings: Item 4a. Duration of Interference
Week 4 · >60 mins
|
0 Participants
|
0 Participants
|
0 Participants
|
|
Intrusive Memory Ratings: Item 4a. Duration of Interference
Week 12 · <1 min
|
12 Participants
|
13 Participants
|
18 Participants
|
|
Intrusive Memory Ratings: Item 4a. Duration of Interference
Week 12 · 1-5 mins
|
5 Participants
|
9 Participants
|
1 Participants
|
|
Intrusive Memory Ratings: Item 4a. Duration of Interference
Week 12 · 6-10 mins
|
2 Participants
|
2 Participants
|
2 Participants
|
|
Intrusive Memory Ratings: Item 4a. Duration of Interference
Week 12 · 11-30 mins
|
0 Participants
|
0 Participants
|
0 Participants
|
|
Intrusive Memory Ratings: Item 4a. Duration of Interference
Week 12 · 31-60 mins
|
0 Participants
|
0 Participants
|
0 Participants
|
|
Intrusive Memory Ratings: Item 4a. Duration of Interference
Week 12 · >60 mins
|
0 Participants
|
0 Participants
|
0 Participants
|
|
Intrusive Memory Ratings: Item 4a. Duration of Interference
Week 24 · <1 min
|
11 Participants
|
9 Participants
|
21 Participants
|
|
Intrusive Memory Ratings: Item 4a. Duration of Interference
Week 24 · 1-5 mins
|
6 Participants
|
13 Participants
|
3 Participants
|
|
Intrusive Memory Ratings: Item 4a. Duration of Interference
Week 24 · 6-10 mins
|
1 Participants
|
1 Participants
|
2 Participants
|
|
Intrusive Memory Ratings: Item 4a. Duration of Interference
Week 24 · 11-30 mins
|
0 Participants
|
1 Participants
|
0 Participants
|
|
Intrusive Memory Ratings: Item 4a. Duration of Interference
Week 24 · 31-60 mins
|
0 Participants
|
0 Participants
|
0 Participants
|
|
Intrusive Memory Ratings: Item 4a. Duration of Interference
Week 24 · >60 mins
|
0 Participants
|
0 Participants
|
0 Participants
|
SECONDARY outcome
Timeframe: Baseline, Week 4, Week 12 and Week 24 (all arms)Population: All analyses were completed on an intention-to-treat basis as a between-group comparison.
This questionnaire assesses a number of intrusive memories characteristics, including frequency (Item 1: 7-point categorical response from 'never' to 'many times a day'); distress (Item 2: 0=not at all to 10=extremely); disruption to concentration (Item 3: 0=not at all to 10=extremely); interference (Item 4: how much (0=not at all to 10=extremely), and Item 4a: for how long (6-point response from '\<1min' to '\>60mins')); impact on work functioning (Item 5: how much (0=not at all to 10=extremely) and Item 6: in what ways (open text response)); impact on functioning in other areas of life (Item 7: how much (0=not at all to 10=extremely) and in what ways (Item 8: open text response)). Here we present data for the five items scored on an 11-point scale (0=not at all to 10=extremely) assessing distress (Item 2), disruption to concentration (Item 3), interference (Item 4), impact on work functioning (Item 5), and impact on functioning in other areas of life (Item 7).
Outcome measures
| Measure |
Treatment As Usual
n=20 Participants
Access to routine care that participants would otherwise receive if having intrusive memories of traumatic events for 24 weeks.
Treatment As Usual: Access to routine care that participants would otherwise receive if having intrusive memories of traumatic events.
|
Brief Digital Music-listening Task
n=39 Participants
Access to a brief digital music-listening task for 24 weeks (first 4 weeks with optional researcher support).
Brief digital music-listening task: First session guided by a researcher: Information about the composer's music followed by listening to classical music.
Option to engage in self-administered/guided sessions after the first session.
|
Brief Digital Imagery-competing Task
n=40 Participants
Access to a brief digital imagery-competing task for 24 weeks (first 4 weeks with optional researcher support).
Brief digital imagery-competing task: First session guided by a researcher: A memory cue followed by playing a computer game with mental rotation instructions.
Option to engage in self-administered/guided sessions after the first session.
|
|---|---|---|---|
|
Intrusive Memory Ratings: Distress (Item 2), Disruption to Concentration (Item 3), Interference (Item 4), Impact on Work Functioning (Item 5), and Impact on Functioning in Other Areas of Life (Item 7)
Baseline - How distressing were your intrusive memories?
|
5.25 score on a scale
Standard Deviation 1.62
|
5.46 score on a scale
Standard Deviation 1.50
|
5.95 score on a scale
Standard Deviation 2.00
|
|
Intrusive Memory Ratings: Distress (Item 2), Disruption to Concentration (Item 3), Interference (Item 4), Impact on Work Functioning (Item 5), and Impact on Functioning in Other Areas of Life (Item 7)
Week 4 - How distressing were your intrusive memories?
|
5.17 score on a scale
Standard Deviation 1.79
|
4.83 score on a scale
Standard Deviation 1.98
|
4.16 score on a scale
Standard Deviation 2.61
|
|
Intrusive Memory Ratings: Distress (Item 2), Disruption to Concentration (Item 3), Interference (Item 4), Impact on Work Functioning (Item 5), and Impact on Functioning in Other Areas of Life (Item 7)
Week 12 - How distressing were your intrusive memories?
|
4.37 score on a scale
Standard Deviation 3.00
|
4.46 score on a scale
Standard Deviation 2.81
|
2.67 score on a scale
Standard Deviation 3.06
|
|
Intrusive Memory Ratings: Distress (Item 2), Disruption to Concentration (Item 3), Interference (Item 4), Impact on Work Functioning (Item 5), and Impact on Functioning in Other Areas of Life (Item 7)
Week 24 - How distressing were your intrusive memories?
|
4.17 score on a scale
Standard Deviation 3.11
|
4.29 score on a scale
Standard Deviation 2.26
|
1.96 score on a scale
Standard Deviation 2.51
|
|
Intrusive Memory Ratings: Distress (Item 2), Disruption to Concentration (Item 3), Interference (Item 4), Impact on Work Functioning (Item 5), and Impact on Functioning in Other Areas of Life (Item 7)
Baseline - How much did they disrupt your concentration?
|
5.80 score on a scale
Standard Deviation 2.42
|
6.31 score on a scale
Standard Deviation 2.31
|
6.55 score on a scale
Standard Deviation 2.32
|
|
Intrusive Memory Ratings: Distress (Item 2), Disruption to Concentration (Item 3), Interference (Item 4), Impact on Work Functioning (Item 5), and Impact on Functioning in Other Areas of Life (Item 7)
Week 4 - How much did they disrupt your concentration?
|
5.28 score on a scale
Standard Deviation 2.14
|
5.17 score on a scale
Standard Deviation 2.45
|
4.36 score on a scale
Standard Deviation 2.60
|
|
Intrusive Memory Ratings: Distress (Item 2), Disruption to Concentration (Item 3), Interference (Item 4), Impact on Work Functioning (Item 5), and Impact on Functioning in Other Areas of Life (Item 7)
Week 12 - How much did they disrupt your concentration?
|
4.68 score on a scale
Standard Deviation 3.23
|
4.50 score on a scale
Standard Deviation 3.02
|
2.43 score on a scale
Standard Deviation 2.98
|
|
Intrusive Memory Ratings: Distress (Item 2), Disruption to Concentration (Item 3), Interference (Item 4), Impact on Work Functioning (Item 5), and Impact on Functioning in Other Areas of Life (Item 7)
Week 24 - How much did they disrupt your concentration?
|
4.06 score on a scale
Standard Deviation 3.57
|
4.04 score on a scale
Standard Deviation 2.39
|
1.88 score on a scale
Standard Deviation 2.66
|
|
Intrusive Memory Ratings: Distress (Item 2), Disruption to Concentration (Item 3), Interference (Item 4), Impact on Work Functioning (Item 5), and Impact on Functioning in Other Areas of Life (Item 7)
Baseline - How much did they interfere with what you were doing?
|
4.65 score on a scale
Standard Deviation 2.23
|
5.44 score on a scale
Standard Deviation 2.15
|
6.18 score on a scale
Standard Deviation 2.49
|
|
Intrusive Memory Ratings: Distress (Item 2), Disruption to Concentration (Item 3), Interference (Item 4), Impact on Work Functioning (Item 5), and Impact on Functioning in Other Areas of Life (Item 7)
Week 4 - How much did they interfere with what you were doing?
|
4.44 score on a scale
Standard Deviation 1.89
|
4.59 score on a scale
Standard Deviation 2.44
|
3.84 score on a scale
Standard Deviation 2.56
|
|
Intrusive Memory Ratings: Distress (Item 2), Disruption to Concentration (Item 3), Interference (Item 4), Impact on Work Functioning (Item 5), and Impact on Functioning in Other Areas of Life (Item 7)
Week 12 - How much did they interfere with what you were doing?
|
4.05 score on a scale
Standard Deviation 3.10
|
3.67 score on a scale
Standard Deviation 2.93
|
2.05 score on a scale
Standard Deviation 2.82
|
|
Intrusive Memory Ratings: Distress (Item 2), Disruption to Concentration (Item 3), Interference (Item 4), Impact on Work Functioning (Item 5), and Impact on Functioning in Other Areas of Life (Item 7)
Week 24 - How much did they interfere with what you were doing?
|
3.22 score on a scale
Standard Deviation 3.32
|
3.63 score on a scale
Standard Deviation 2.55
|
1.54 score on a scale
Standard Deviation 2.25
|
|
Intrusive Memory Ratings: Distress (Item 2), Disruption to Concentration (Item 3), Interference (Item 4), Impact on Work Functioning (Item 5), and Impact on Functioning in Other Areas of Life (Item 7)
Baseline - How much did your intrusive memories affect your work functioning?
|
3.70 score on a scale
Standard Deviation 2.62
|
4.77 score on a scale
Standard Deviation 2.45
|
4.75 score on a scale
Standard Deviation 2.72
|
|
Intrusive Memory Ratings: Distress (Item 2), Disruption to Concentration (Item 3), Interference (Item 4), Impact on Work Functioning (Item 5), and Impact on Functioning in Other Areas of Life (Item 7)
Week 4 - How much did your intrusive memories affect your work functioning?
|
3.72 score on a scale
Standard Deviation 2.59
|
3.55 score on a scale
Standard Deviation 2.75
|
2.80 score on a scale
Standard Deviation 2.81
|
|
Intrusive Memory Ratings: Distress (Item 2), Disruption to Concentration (Item 3), Interference (Item 4), Impact on Work Functioning (Item 5), and Impact on Functioning in Other Areas of Life (Item 7)
Week 12 - How much did your intrusive memories affect your work functioning?
|
3.16 score on a scale
Standard Deviation 3.73
|
2.96 score on a scale
Standard Deviation 3.14
|
1.38 score on a scale
Standard Deviation 2.50
|
|
Intrusive Memory Ratings: Distress (Item 2), Disruption to Concentration (Item 3), Interference (Item 4), Impact on Work Functioning (Item 5), and Impact on Functioning in Other Areas of Life (Item 7)
Week 24 - How much did your intrusive memories affect your work functioning?
|
2.67 score on a scale
Standard Deviation 3.33
|
2.75 score on a scale
Standard Deviation 3.01
|
0.96 score on a scale
Standard Deviation 1.78
|
|
Intrusive Memory Ratings: Distress (Item 2), Disruption to Concentration (Item 3), Interference (Item 4), Impact on Work Functioning (Item 5), and Impact on Functioning in Other Areas of Life (Item 7)
Baseline - How much did your intrusive memories affect your functioning in other areas of your life?
|
4.80 score on a scale
Standard Deviation 2.57
|
4.72 score on a scale
Standard Deviation 2.45
|
5.48 score on a scale
Standard Deviation 2.74
|
|
Intrusive Memory Ratings: Distress (Item 2), Disruption to Concentration (Item 3), Interference (Item 4), Impact on Work Functioning (Item 5), and Impact on Functioning in Other Areas of Life (Item 7)
Week 4 - How much did your intrusive memories affect your functioning in other areas of your life?
|
4.17 score on a scale
Standard Deviation 2.33
|
4.21 score on a scale
Standard Deviation 2.99
|
2.96 score on a scale
Standard Deviation 2.73
|
|
Intrusive Memory Ratings: Distress (Item 2), Disruption to Concentration (Item 3), Interference (Item 4), Impact on Work Functioning (Item 5), and Impact on Functioning in Other Areas of Life (Item 7)
Week 12 - How much did your intrusive memories affect your functioning in other areas of your life?
|
3.79 score on a scale
Standard Deviation 3.66
|
2.96 score on a scale
Standard Deviation 3.03
|
1.48 score on a scale
Standard Deviation 2.44
|
|
Intrusive Memory Ratings: Distress (Item 2), Disruption to Concentration (Item 3), Interference (Item 4), Impact on Work Functioning (Item 5), and Impact on Functioning in Other Areas of Life (Item 7)
Week 24 - How much did your intrusive memories affect your functioning in other areas of your life?
|
2.22 score on a scale
Standard Deviation 2.82
|
2.50 score on a scale
Standard Deviation 2.67
|
0.96 score on a scale
Standard Deviation 1.59
|
OTHER_PRE_SPECIFIED outcome
Timeframe: 4 weeks, 12 weeks and 24 weeks (all arms)Population: Analyses were completed on an intention-to-treat basis.
The 9-item questionnaire will be used to assess the occurrence and number of any new traumatic events, any additional stressful life events (e.g. relationship problems, financial problems), new treatments received, untoward medical occurrences, changes to the job, or changes to the number of hours worked per week since the last assessment. Dichotomous outcomes are presented below, and discrete outcomes with count data are presented under "Changes to health and work - discrete outcomes".
Outcome measures
| Measure |
Treatment As Usual
n=19 Participants
Access to routine care that participants would otherwise receive if having intrusive memories of traumatic events for 24 weeks.
Treatment As Usual: Access to routine care that participants would otherwise receive if having intrusive memories of traumatic events.
|
Brief Digital Music-listening Task
n=30 Participants
Access to a brief digital music-listening task for 24 weeks (first 4 weeks with optional researcher support).
Brief digital music-listening task: First session guided by a researcher: Information about the composer's music followed by listening to classical music.
Option to engage in self-administered/guided sessions after the first session.
|
Brief Digital Imagery-competing Task
n=25 Participants
Access to a brief digital imagery-competing task for 24 weeks (first 4 weeks with optional researcher support).
Brief digital imagery-competing task: First session guided by a researcher: A memory cue followed by playing a computer game with mental rotation instructions.
Option to engage in self-administered/guided sessions after the first session.
|
|---|---|---|---|
|
Changes to Health and Work - Dichotomous Outcomes
Week 4 - Have you experienced or witnessed any new work-related traumatic events? · No
|
8 Participants
|
20 Participants
|
18 Participants
|
|
Changes to Health and Work - Dichotomous Outcomes
Week 12 - Have you experienced or witnessed any new work-related traumatic events? · Yes
|
8 Participants
|
3 Participants
|
8 Participants
|
|
Changes to Health and Work - Dichotomous Outcomes
Week 12 - Have you experienced or witnessed any new work-related traumatic events? · No
|
11 Participants
|
21 Participants
|
13 Participants
|
|
Changes to Health and Work - Dichotomous Outcomes
Week 24 - Have you experienced or witnessed any new work-related traumatic events? · Yes
|
4 Participants
|
8 Participants
|
5 Participants
|
|
Changes to Health and Work - Dichotomous Outcomes
Week 4 - Have you experienced or witnessed any new work-related traumatic events? · Yes
|
9 Participants
|
6 Participants
|
6 Participants
|
|
Changes to Health and Work - Dichotomous Outcomes
Week 24 - Have you experienced or witnessed any new work-related traumatic events? · No
|
12 Participants
|
16 Participants
|
20 Participants
|
OTHER_PRE_SPECIFIED outcome
Timeframe: 4 weeks, 12 weeks and 24 weeks (all arms)Population: Analyses were completed on an intention-to-treat basis.
The 9-item questionnaire will be used to assess the occurrence and number of any new traumatic events, any additional stressful life events (e.g. relationship problems, financial problems), new treatments received, untoward medical occurrences, changes to the job, or changes to the number of hours worked per week since the last assessment. Discrete outcomes are presented below, and dichotomous outcomes are presented under "Changes to health and work - dichotomous outcomes".
Outcome measures
| Measure |
Treatment As Usual
n=19 Participants
Access to routine care that participants would otherwise receive if having intrusive memories of traumatic events for 24 weeks.
Treatment As Usual: Access to routine care that participants would otherwise receive if having intrusive memories of traumatic events.
|
Brief Digital Music-listening Task
n=30 Participants
Access to a brief digital music-listening task for 24 weeks (first 4 weeks with optional researcher support).
Brief digital music-listening task: First session guided by a researcher: Information about the composer's music followed by listening to classical music.
Option to engage in self-administered/guided sessions after the first session.
|
Brief Digital Imagery-competing Task
n=25 Participants
Access to a brief digital imagery-competing task for 24 weeks (first 4 weeks with optional researcher support).
Brief digital imagery-competing task: First session guided by a researcher: A memory cue followed by playing a computer game with mental rotation instructions.
Option to engage in self-administered/guided sessions after the first session.
|
|---|---|---|---|
|
Changes to Health and Work - Discrete Outcomes
Week 4 - How many new work-related traumatic events have you experienced/witnessed?
|
1.53 number of events
Standard Deviation 2.67
|
0.62 number of events
Standard Deviation 1.20
|
0.75 number of events
Standard Deviation 1.36
|
|
Changes to Health and Work - Discrete Outcomes
Week 12 - How many new work-related traumatic events have you experienced/witnessed?
|
1.05 number of events
Standard Deviation 1.93
|
0.46 number of events
Standard Deviation 1.14
|
1.52 number of events
Standard Deviation 2.58
|
|
Changes to Health and Work - Discrete Outcomes
Week 24 - How many new work-related traumatic events have you experienced/witnessed?
|
0.75 number of events
Standard Deviation 1.39
|
1.04 number of events
Standard Deviation 2.01
|
0.96 number of events
Standard Deviation 2.76
|
|
Changes to Health and Work - Discrete Outcomes
Week 4 - How many new traumatic events that were not work-related have you experienced/witnessed?
|
0.06 number of events
Standard Deviation 0.24
|
0.15 number of events
Standard Deviation 0.46
|
0.13 number of events
Standard Deviation 0.34
|
|
Changes to Health and Work - Discrete Outcomes
Week 12 - How many new traumatic events that were not work-related have you experienced/witnessed?
|
0.37 number of events
Standard Deviation 0.76
|
0.17 number of events
Standard Deviation 0.48
|
0.52 number of events
Standard Deviation 0.93
|
|
Changes to Health and Work - Discrete Outcomes
Week 24 - How many new traumatic events that were not work-related have you experienced/witnessed?
|
0.13 number of events
Standard Deviation 0.34
|
0.29 number of events
Standard Deviation 0.75
|
0.16 number of events
Standard Deviation 0.37
|
OTHER_PRE_SPECIFIED outcome
Timeframe: After 4 weeks (brief imagery-competing task and brief music listening task arms only)Population: All analyses were completed on an intention-to-treat basis as a between-group comparison.
A 12-item questionnaire assessing participants' experience of using the brief cognitive task. The first ten items assess how easy, helpful, distressing, burdensome and acceptable participants found the brief cognitive task, how willing they would be to use it in the future, how confident they would be in recommending it to a friend and how much they feel it could be used to support staff within the NHS, each rated from 0 (not at all) to 10 (very). The last two items ask how the brief cognitive task could be improved, and for any other comments or suggestions about the brief cogntive task, both with an open response.
Outcome measures
| Measure |
Treatment As Usual
n=22 Participants
Access to routine care that participants would otherwise receive if having intrusive memories of traumatic events for 24 weeks.
Treatment As Usual: Access to routine care that participants would otherwise receive if having intrusive memories of traumatic events.
|
Brief Digital Music-listening Task
n=25 Participants
Access to a brief digital music-listening task for 24 weeks (first 4 weeks with optional researcher support).
Brief digital music-listening task: First session guided by a researcher: Information about the composer's music followed by listening to classical music.
Option to engage in self-administered/guided sessions after the first session.
|
Brief Digital Imagery-competing Task
Access to a brief digital imagery-competing task for 24 weeks (first 4 weeks with optional researcher support).
Brief digital imagery-competing task: First session guided by a researcher: A memory cue followed by playing a computer game with mental rotation instructions.
Option to engage in self-administered/guided sessions after the first session.
|
|---|---|---|---|
|
Feedback Questionnaire
How easy did you find it to use the brief cognitive task?
|
8.36 score on a scale
Standard Deviation 2.90
|
8.76 score on a scale
Standard Deviation 1.61
|
—
|
|
Feedback Questionnaire
How helpful did you find the brief cognitive task?
|
5.05 score on a scale
Standard Deviation 2.98
|
8.04 score on a scale
Standard Deviation 1.77
|
—
|
|
Feedback Questionnaire
How burdensome did you find the brief cognitive task?
|
6.05 score on a scale
Standard Deviation 3.11
|
6.56 score on a scale
Standard Deviation 1.87
|
—
|
|
Feedback Questionnaire
How distressing did you find the brief cognitive task?
|
9.36 score on a scale
Standard Deviation 1.18
|
8.24 score on a scale
Standard Deviation 1.88
|
—
|
|
Feedback Questionnaire
Overall, how acceptable did you find the brief cognitive task?
|
6.50 score on a scale
Standard Deviation 2.79
|
7.92 score on a scale
Standard Deviation 2.33
|
—
|
|
Feedback Questionnaire
If you were having intrusive memories in future, how willing would you be to use the cognitive task?
|
5.86 score on a scale
Standard Deviation 3.66
|
8.08 score on a scale
Standard Deviation 1.98
|
—
|
|
Feedback Questionnaire
How confident would you be recommending the brief cognitive task to others with intrusive memories?
|
5.32 score on a scale
Standard Deviation 3.58
|
7.68 score on a scale
Standard Deviation 2.21
|
—
|
|
Feedback Questionnaire
How much do you feel that this brief cognitive task could be used within NHS Trusts?
|
5.55 score on a scale
Standard Deviation 3.31
|
8.00 score on a scale
Standard Deviation 2.06
|
—
|
OTHER_PRE_SPECIFIED outcome
Timeframe: After 4 weeks (brief imagery-competing task and brief music listening task arms only)Population: All analyses were completed on an intention-to-treat basis as a between-group comparison.
A 12-item questionnaire assessing participants' experience of using the brief cognitive task. The first ten items assess how easy, helpful, distressing, burdensome and acceptable participants found the brief cognitive task, how willing they would be to use it in the future, how confident they would be in recommending it to a friend and how much they feel it could be used to support staff within the NHS, each rated from 0 (not at all) to 10 (very); items for distress and burden are reverse scored from 0 (very) to 10 (not at all). The last two items ask how the brief cognitive task could be improved, and for any other comments or suggestions about the brief cognitive task, both with an open response. A total score of the eight categorical items is presented (range 0 - 80), with greater scores indicating more favourable feedback towards the allocated digital task.
Outcome measures
| Measure |
Treatment As Usual
n=22 Participants
Access to routine care that participants would otherwise receive if having intrusive memories of traumatic events for 24 weeks.
Treatment As Usual: Access to routine care that participants would otherwise receive if having intrusive memories of traumatic events.
|
Brief Digital Music-listening Task
n=25 Participants
Access to a brief digital music-listening task for 24 weeks (first 4 weeks with optional researcher support).
Brief digital music-listening task: First session guided by a researcher: Information about the composer's music followed by listening to classical music.
Option to engage in self-administered/guided sessions after the first session.
|
Brief Digital Imagery-competing Task
Access to a brief digital imagery-competing task for 24 weeks (first 4 weeks with optional researcher support).
Brief digital imagery-competing task: First session guided by a researcher: A memory cue followed by playing a computer game with mental rotation instructions.
Option to engage in self-administered/guided sessions after the first session.
|
|---|---|---|---|
|
Feedback Questionnaire (Total Score)
|
52.05 score on a scale
Standard Deviation 19.17
|
63.28 score on a scale
Standard Deviation 11.71
|
—
|
OTHER_PRE_SPECIFIED outcome
Timeframe: Week 4 and Week 24 (brief imagery competing task and brief music listening task arms only)Population: Participants randomised to the brief digital music-listening task or brief digital imagery-competing task who consented to participate in the optional qualitative interview at Week 4 and Week 24. Two participants allocated to the brief digital imagery-competing task completed both week 4 and week 24 qualitative interviews.
This semi-structured interview will consist of a number of questions designed to gain an in-depth understanding of participants' experience of using the brief cognitive task, including acceptability, improvement suggestions, and potential barriers/facilitators to implementation.
Outcome measures
| Measure |
Treatment As Usual
n=11 Participants
Access to routine care that participants would otherwise receive if having intrusive memories of traumatic events for 24 weeks.
Treatment As Usual: Access to routine care that participants would otherwise receive if having intrusive memories of traumatic events.
|
Brief Digital Music-listening Task
n=14 Participants
Access to a brief digital music-listening task for 24 weeks (first 4 weeks with optional researcher support).
Brief digital music-listening task: First session guided by a researcher: Information about the composer's music followed by listening to classical music.
Option to engage in self-administered/guided sessions after the first session.
|
Brief Digital Imagery-competing Task
Access to a brief digital imagery-competing task for 24 weeks (first 4 weeks with optional researcher support).
Brief digital imagery-competing task: First session guided by a researcher: A memory cue followed by playing a computer game with mental rotation instructions.
Option to engage in self-administered/guided sessions after the first session.
|
|---|---|---|---|
|
Optional Qualitative Interview
Participated in optional qualitative interview at Week 4
|
7 Participants
|
8 Participants
|
—
|
|
Optional Qualitative Interview
Participated in optional qualitative interview at Week 24
|
4 Participants
|
8 Participants
|
—
|
OTHER_PRE_SPECIFIED outcome
Timeframe: Baseline, Week 4, Week 12 and Week 24Population: All analyses were completed on an intention-to-treat basis as a between-group comparison.
One item asses the number of days worked in the last week (both with responses from 0 to 7 days).
Outcome measures
| Measure |
Treatment As Usual
n=20 Participants
Access to routine care that participants would otherwise receive if having intrusive memories of traumatic events for 24 weeks.
Treatment As Usual: Access to routine care that participants would otherwise receive if having intrusive memories of traumatic events.
|
Brief Digital Music-listening Task
n=39 Participants
Access to a brief digital music-listening task for 24 weeks (first 4 weeks with optional researcher support).
Brief digital music-listening task: First session guided by a researcher: Information about the composer's music followed by listening to classical music.
Option to engage in self-administered/guided sessions after the first session.
|
Brief Digital Imagery-competing Task
n=40 Participants
Access to a brief digital imagery-competing task for 24 weeks (first 4 weeks with optional researcher support).
Brief digital imagery-competing task: First session guided by a researcher: A memory cue followed by playing a computer game with mental rotation instructions.
Option to engage in self-administered/guided sessions after the first session.
|
|---|---|---|---|
|
Weekly Work Pattern, Number of Days Worked
Baseline
|
3.95 Days
Standard Deviation 1.47
|
3.00 Days
Standard Deviation 1.91
|
3.68 Days
Standard Deviation 1.80
|
|
Weekly Work Pattern, Number of Days Worked
Week 4
|
3.67 Days
Standard Deviation 1.50
|
3.28 Days
Standard Deviation 2.15
|
3.12 Days
Standard Deviation 1.67
|
|
Weekly Work Pattern, Number of Days Worked
Week 12
|
3.68 Days
Standard Deviation 1.53
|
3.00 Days
Standard Deviation 1.62
|
3.76 Days
Standard Deviation 1.76
|
|
Weekly Work Pattern, Number of Days Worked
Week 24
|
3.28 Days
Standard Deviation 2.08
|
2.92 Days
Standard Deviation 1.93
|
2.85 Days
Standard Deviation 1.99
|
OTHER_PRE_SPECIFIED outcome
Timeframe: Baseline, Week 4, Week 12 and Week 24Population: All analyses were completed on an intention-to-treat basis as a between-group comparison.
One item asses the number of night shifts worked in the last week (both with responses from 0 to 7).
Outcome measures
| Measure |
Treatment As Usual
n=20 Participants
Access to routine care that participants would otherwise receive if having intrusive memories of traumatic events for 24 weeks.
Treatment As Usual: Access to routine care that participants would otherwise receive if having intrusive memories of traumatic events.
|
Brief Digital Music-listening Task
n=39 Participants
Access to a brief digital music-listening task for 24 weeks (first 4 weeks with optional researcher support).
Brief digital music-listening task: First session guided by a researcher: Information about the composer's music followed by listening to classical music.
Option to engage in self-administered/guided sessions after the first session.
|
Brief Digital Imagery-competing Task
n=40 Participants
Access to a brief digital imagery-competing task for 24 weeks (first 4 weeks with optional researcher support).
Brief digital imagery-competing task: First session guided by a researcher: A memory cue followed by playing a computer game with mental rotation instructions.
Option to engage in self-administered/guided sessions after the first session.
|
|---|---|---|---|
|
Weekly Work Pattern, Number of Night Shifts Worked
Week 4
|
0.17 Nights
Standard Deviation 0.71
|
0.00 Nights
Standard Deviation 0.00
|
0.32 Nights
Standard Deviation 0.75
|
|
Weekly Work Pattern, Number of Night Shifts Worked
Week 12
|
0.26 Nights
Standard Deviation 0.81
|
0.29 Nights
Standard Deviation 0.86
|
0.24 Nights
Standard Deviation 0.77
|
|
Weekly Work Pattern, Number of Night Shifts Worked
Week 24
|
0.61 Nights
Standard Deviation 1.46
|
0.13 Nights
Standard Deviation 0.61
|
0.42 Nights
Standard Deviation 0.99
|
|
Weekly Work Pattern, Number of Night Shifts Worked
Baseline
|
0.50 Nights
Standard Deviation 1.00
|
0.36 Nights
Standard Deviation 1.29
|
0.15 Nights
Standard Deviation 0.43
|
OTHER_PRE_SPECIFIED outcome
Timeframe: Day 0 (post-randomisation)Population: Analyses were completed on an intention-to-treat basis.
The Credibility and Expectancy Questionnaire (CEQ) consists of 6 items. Items 1, 2, 3, and 5 were assessed on a 9-point integer scale ranging from 1 ("not at all") to 9 ("very"). Items 4 and 6 were assessed on an 11-point scale (response range of 0-100%) and, for comparability, were converted to the same 9-point scale as other items. CEQ total score was calculated by summing all six items producing a possible total score range of 6-54; with greater scores indicating greater credibility and expectancy of intervention effect. Participants completed the Credibility and Expectancy Questionnaire (CEQ) after being informed of treatment allocation (Day 0).
Outcome measures
| Measure |
Treatment As Usual
n=19 Participants
Access to routine care that participants would otherwise receive if having intrusive memories of traumatic events for 24 weeks.
Treatment As Usual: Access to routine care that participants would otherwise receive if having intrusive memories of traumatic events.
|
Brief Digital Music-listening Task
n=35 Participants
Access to a brief digital music-listening task for 24 weeks (first 4 weeks with optional researcher support).
Brief digital music-listening task: First session guided by a researcher: Information about the composer's music followed by listening to classical music.
Option to engage in self-administered/guided sessions after the first session.
|
Brief Digital Imagery-competing Task
n=34 Participants
Access to a brief digital imagery-competing task for 24 weeks (first 4 weeks with optional researcher support).
Brief digital imagery-competing task: First session guided by a researcher: A memory cue followed by playing a computer game with mental rotation instructions.
Option to engage in self-administered/guided sessions after the first session.
|
|---|---|---|---|
|
Expectancy of Intervention Effect (Credibility and Expectancy Questionnaire, CEQ) - Categorical Items
At this point, how logical does the intervention offered to you seem?
|
4.4 score on a scale
Standard Deviation 2.5
|
6.8 score on a scale
Standard Deviation 1.3
|
5.9 score on a scale
Standard Deviation 1.9
|
|
Expectancy of Intervention Effect (Credibility and Expectancy Questionnaire, CEQ) - Categorical Items
How successful do you think this intervention will be in reducing your intrusive memories?
|
2.9 score on a scale
Standard Deviation 1.7
|
5.8 score on a scale
Standard Deviation 1.5
|
5.4 score on a scale
Standard Deviation 1.9
|
|
Expectancy of Intervention Effect (Credibility and Expectancy Questionnaire, CEQ) - Categorical Items
How confident would you be recommending this intervention to a friend experiencing similar problems?
|
2.8 score on a scale
Standard Deviation 2.3
|
6.2 score on a scale
Standard Deviation 2.0
|
5.4 score on a scale
Standard Deviation 2.2
|
|
Expectancy of Intervention Effect (Credibility and Expectancy Questionnaire, CEQ) - Categorical Items
By the end of the intervention, how much improvement in intrusive memories do you think will occur?
|
2.6 score on a scale
Standard Deviation 2.1
|
5.6 score on a scale
Standard Deviation 1.6
|
5.0 score on a scale
Standard Deviation 2.0
|
|
Expectancy of Intervention Effect (Credibility and Expectancy Questionnaire, CEQ) - Categorical Items
How much do you really feel that the intervention will help you to reduce your intrusive memories?
|
2.3 score on a scale
Standard Deviation 1.7
|
5.9 score on a scale
Standard Deviation 1.8
|
5.4 score on a scale
Standard Deviation 2.4
|
|
Expectancy of Intervention Effect (Credibility and Expectancy Questionnaire, CEQ) - Categorical Items
How much improvement in your intrusive memories do you really feel will occur?
|
2.2 score on a scale
Standard Deviation 1.7
|
5.7 score on a scale
Standard Deviation 1.8
|
5.0 score on a scale
Standard Deviation 2.4
|
OTHER_PRE_SPECIFIED outcome
Timeframe: Day 0 (post-randomisation)Population: Analyses were completed on an intention-to-treat basis.
The Credibility and Expectancy Questionnaire (CEQ) consists of 6 items. Items 1, 2, 3, and 5 were assessed on a 9-point integer scale ranging from 1 ("not at all") to 9 ("very"). Items 4 and 6 were assessed on an 11-point scale (response range of 0-100%) and, for comparability, were converted to the same 9-point scale as other items. CEQ total score was calculated by summing all six items producing a possible total score range of 6-54; with greater scores indicating greater credibility and expectancy of intervention effect. Participants completed the Credibility and Expectancy Questionnaire (CEQ) after being informed of treatment allocation (Day 0).
Outcome measures
| Measure |
Treatment As Usual
n=19 Participants
Access to routine care that participants would otherwise receive if having intrusive memories of traumatic events for 24 weeks.
Treatment As Usual: Access to routine care that participants would otherwise receive if having intrusive memories of traumatic events.
|
Brief Digital Music-listening Task
n=35 Participants
Access to a brief digital music-listening task for 24 weeks (first 4 weeks with optional researcher support).
Brief digital music-listening task: First session guided by a researcher: Information about the composer's music followed by listening to classical music.
Option to engage in self-administered/guided sessions after the first session.
|
Brief Digital Imagery-competing Task
n=34 Participants
Access to a brief digital imagery-competing task for 24 weeks (first 4 weeks with optional researcher support).
Brief digital imagery-competing task: First session guided by a researcher: A memory cue followed by playing a computer game with mental rotation instructions.
Option to engage in self-administered/guided sessions after the first session.
|
|---|---|---|---|
|
Expectancy of Intervention Effect (Credibility and Expectancy Questionnaire, CEQ) - Total Score
|
17.2 total score on a scale
Standard Deviation 10.3
|
35.9 total score on a scale
Standard Deviation 8.2
|
32.1 total score on a scale
Standard Deviation 11.4
|
Adverse Events
Brief Digital Music-listening Task
Brief Digital Imagery-competing Task
Treatment As Usual
Run-in Week (Pre-randomised and Non-randomised)
Serious adverse events
| Measure |
Brief Digital Music-listening Task
n=39 participants at risk
Access to a brief digital music-listening task for 24 weeks (first 4 weeks with optional researcher support).
Brief digital music-listening task: First session guided by a researcher: Information about the composer's music followed by listening to classical music.
Option to engage in self-administered/guided sessions after the first session.
|
Brief Digital Imagery-competing Task
n=40 participants at risk
Access to a brief digital imagery-competing task for 24 weeks (first 4 weeks with optional researcher support).
Brief digital imagery-competing task: First session guided by a researcher: A memory cue followed by playing a computer game with mental rotation instructions.
Option to engage in self-administered/guided sessions after the first session.
|
Treatment As Usual
n=20 participants at risk
Access to routine care that participants would otherwise receive if having intrusive memories of traumatic events for 24 weeks.
|
Run-in Week (Pre-randomised and Non-randomised)
n=122 participants at risk
This study used a run-in week to establish a baseline number of intrusive memories over a seven-day period.
Participants were randomised if they completed the run-in week, recorded at least three intrusive memories during the run-in week, and completed baseline questionnaires. N=23 participants commenced the run-in week and could not be randomised to experimental arm.
No data are available for those participants were not randomised.
|
|---|---|---|---|---|
|
Reproductive system and breast disorders
Endometriosis
|
0.00%
0/39 • Adverse events were surveyed throughout the trial, from enrolment to Week 24.
All participants were asked to report adverse events, including any additional stressful life events or new treatments, with both passive (reported throughout the trial) and active surveillance (open ended questions at 4, 12 and 24 weeks).
|
2.5%
1/40 • Number of events 1 • Adverse events were surveyed throughout the trial, from enrolment to Week 24.
All participants were asked to report adverse events, including any additional stressful life events or new treatments, with both passive (reported throughout the trial) and active surveillance (open ended questions at 4, 12 and 24 weeks).
|
0.00%
0/20 • Adverse events were surveyed throughout the trial, from enrolment to Week 24.
All participants were asked to report adverse events, including any additional stressful life events or new treatments, with both passive (reported throughout the trial) and active surveillance (open ended questions at 4, 12 and 24 weeks).
|
0.00%
0/122 • Adverse events were surveyed throughout the trial, from enrolment to Week 24.
All participants were asked to report adverse events, including any additional stressful life events or new treatments, with both passive (reported throughout the trial) and active surveillance (open ended questions at 4, 12 and 24 weeks).
|
|
Infections and infestations
Kidney infection
|
0.00%
0/39 • Adverse events were surveyed throughout the trial, from enrolment to Week 24.
All participants were asked to report adverse events, including any additional stressful life events or new treatments, with both passive (reported throughout the trial) and active surveillance (open ended questions at 4, 12 and 24 weeks).
|
2.5%
1/40 • Number of events 1 • Adverse events were surveyed throughout the trial, from enrolment to Week 24.
All participants were asked to report adverse events, including any additional stressful life events or new treatments, with both passive (reported throughout the trial) and active surveillance (open ended questions at 4, 12 and 24 weeks).
|
0.00%
0/20 • Adverse events were surveyed throughout the trial, from enrolment to Week 24.
All participants were asked to report adverse events, including any additional stressful life events or new treatments, with both passive (reported throughout the trial) and active surveillance (open ended questions at 4, 12 and 24 weeks).
|
0.00%
0/122 • Adverse events were surveyed throughout the trial, from enrolment to Week 24.
All participants were asked to report adverse events, including any additional stressful life events or new treatments, with both passive (reported throughout the trial) and active surveillance (open ended questions at 4, 12 and 24 weeks).
|
|
Infections and infestations
Pneumonia
|
2.6%
1/39 • Number of events 1 • Adverse events were surveyed throughout the trial, from enrolment to Week 24.
All participants were asked to report adverse events, including any additional stressful life events or new treatments, with both passive (reported throughout the trial) and active surveillance (open ended questions at 4, 12 and 24 weeks).
|
0.00%
0/40 • Adverse events were surveyed throughout the trial, from enrolment to Week 24.
All participants were asked to report adverse events, including any additional stressful life events or new treatments, with both passive (reported throughout the trial) and active surveillance (open ended questions at 4, 12 and 24 weeks).
|
0.00%
0/20 • Adverse events were surveyed throughout the trial, from enrolment to Week 24.
All participants were asked to report adverse events, including any additional stressful life events or new treatments, with both passive (reported throughout the trial) and active surveillance (open ended questions at 4, 12 and 24 weeks).
|
0.00%
0/122 • Adverse events were surveyed throughout the trial, from enrolment to Week 24.
All participants were asked to report adverse events, including any additional stressful life events or new treatments, with both passive (reported throughout the trial) and active surveillance (open ended questions at 4, 12 and 24 weeks).
|
|
Infections and infestations
Post-operative infection (hysteroscopy)
|
2.6%
1/39 • Number of events 1 • Adverse events were surveyed throughout the trial, from enrolment to Week 24.
All participants were asked to report adverse events, including any additional stressful life events or new treatments, with both passive (reported throughout the trial) and active surveillance (open ended questions at 4, 12 and 24 weeks).
|
0.00%
0/40 • Adverse events were surveyed throughout the trial, from enrolment to Week 24.
All participants were asked to report adverse events, including any additional stressful life events or new treatments, with both passive (reported throughout the trial) and active surveillance (open ended questions at 4, 12 and 24 weeks).
|
0.00%
0/20 • Adverse events were surveyed throughout the trial, from enrolment to Week 24.
All participants were asked to report adverse events, including any additional stressful life events or new treatments, with both passive (reported throughout the trial) and active surveillance (open ended questions at 4, 12 and 24 weeks).
|
0.00%
0/122 • Adverse events were surveyed throughout the trial, from enrolment to Week 24.
All participants were asked to report adverse events, including any additional stressful life events or new treatments, with both passive (reported throughout the trial) and active surveillance (open ended questions at 4, 12 and 24 weeks).
|
|
Infections and infestations
Septic shock
|
0.00%
0/39 • Adverse events were surveyed throughout the trial, from enrolment to Week 24.
All participants were asked to report adverse events, including any additional stressful life events or new treatments, with both passive (reported throughout the trial) and active surveillance (open ended questions at 4, 12 and 24 weeks).
|
2.5%
1/40 • Number of events 1 • Adverse events were surveyed throughout the trial, from enrolment to Week 24.
All participants were asked to report adverse events, including any additional stressful life events or new treatments, with both passive (reported throughout the trial) and active surveillance (open ended questions at 4, 12 and 24 weeks).
|
0.00%
0/20 • Adverse events were surveyed throughout the trial, from enrolment to Week 24.
All participants were asked to report adverse events, including any additional stressful life events or new treatments, with both passive (reported throughout the trial) and active surveillance (open ended questions at 4, 12 and 24 weeks).
|
0.00%
0/122 • Adverse events were surveyed throughout the trial, from enrolment to Week 24.
All participants were asked to report adverse events, including any additional stressful life events or new treatments, with both passive (reported throughout the trial) and active surveillance (open ended questions at 4, 12 and 24 weeks).
|
|
Surgical and medical procedures
Surgery for cervical myelopathy
|
2.6%
1/39 • Number of events 1 • Adverse events were surveyed throughout the trial, from enrolment to Week 24.
All participants were asked to report adverse events, including any additional stressful life events or new treatments, with both passive (reported throughout the trial) and active surveillance (open ended questions at 4, 12 and 24 weeks).
|
0.00%
0/40 • Adverse events were surveyed throughout the trial, from enrolment to Week 24.
All participants were asked to report adverse events, including any additional stressful life events or new treatments, with both passive (reported throughout the trial) and active surveillance (open ended questions at 4, 12 and 24 weeks).
|
0.00%
0/20 • Adverse events were surveyed throughout the trial, from enrolment to Week 24.
All participants were asked to report adverse events, including any additional stressful life events or new treatments, with both passive (reported throughout the trial) and active surveillance (open ended questions at 4, 12 and 24 weeks).
|
0.00%
0/122 • Adverse events were surveyed throughout the trial, from enrolment to Week 24.
All participants were asked to report adverse events, including any additional stressful life events or new treatments, with both passive (reported throughout the trial) and active surveillance (open ended questions at 4, 12 and 24 weeks).
|
Other adverse events
| Measure |
Brief Digital Music-listening Task
n=39 participants at risk
Access to a brief digital music-listening task for 24 weeks (first 4 weeks with optional researcher support).
Brief digital music-listening task: First session guided by a researcher: Information about the composer's music followed by listening to classical music.
Option to engage in self-administered/guided sessions after the first session.
|
Brief Digital Imagery-competing Task
n=40 participants at risk
Access to a brief digital imagery-competing task for 24 weeks (first 4 weeks with optional researcher support).
Brief digital imagery-competing task: First session guided by a researcher: A memory cue followed by playing a computer game with mental rotation instructions.
Option to engage in self-administered/guided sessions after the first session.
|
Treatment As Usual
n=20 participants at risk
Access to routine care that participants would otherwise receive if having intrusive memories of traumatic events for 24 weeks.
|
Run-in Week (Pre-randomised and Non-randomised)
n=122 participants at risk
This study used a run-in week to establish a baseline number of intrusive memories over a seven-day period.
Participants were randomised if they completed the run-in week, recorded at least three intrusive memories during the run-in week, and completed baseline questionnaires. N=23 participants commenced the run-in week and could not be randomised to experimental arm.
No data are available for those participants were not randomised.
|
|---|---|---|---|---|
|
Infections and infestations
SARS-CoV-2 Infection
|
7.7%
3/39 • Number of events 3 • Adverse events were surveyed throughout the trial, from enrolment to Week 24.
All participants were asked to report adverse events, including any additional stressful life events or new treatments, with both passive (reported throughout the trial) and active surveillance (open ended questions at 4, 12 and 24 weeks).
|
2.5%
1/40 • Number of events 1 • Adverse events were surveyed throughout the trial, from enrolment to Week 24.
All participants were asked to report adverse events, including any additional stressful life events or new treatments, with both passive (reported throughout the trial) and active surveillance (open ended questions at 4, 12 and 24 weeks).
|
0.00%
0/20 • Adverse events were surveyed throughout the trial, from enrolment to Week 24.
All participants were asked to report adverse events, including any additional stressful life events or new treatments, with both passive (reported throughout the trial) and active surveillance (open ended questions at 4, 12 and 24 weeks).
|
2.5%
3/122 • Number of events 3 • Adverse events were surveyed throughout the trial, from enrolment to Week 24.
All participants were asked to report adverse events, including any additional stressful life events or new treatments, with both passive (reported throughout the trial) and active surveillance (open ended questions at 4, 12 and 24 weeks).
|
|
Infections and infestations
Respiratory illness
|
7.7%
3/39 • Number of events 3 • Adverse events were surveyed throughout the trial, from enrolment to Week 24.
All participants were asked to report adverse events, including any additional stressful life events or new treatments, with both passive (reported throughout the trial) and active surveillance (open ended questions at 4, 12 and 24 weeks).
|
2.5%
1/40 • Number of events 1 • Adverse events were surveyed throughout the trial, from enrolment to Week 24.
All participants were asked to report adverse events, including any additional stressful life events or new treatments, with both passive (reported throughout the trial) and active surveillance (open ended questions at 4, 12 and 24 weeks).
|
0.00%
0/20 • Adverse events were surveyed throughout the trial, from enrolment to Week 24.
All participants were asked to report adverse events, including any additional stressful life events or new treatments, with both passive (reported throughout the trial) and active surveillance (open ended questions at 4, 12 and 24 weeks).
|
0.00%
0/122 • Adverse events were surveyed throughout the trial, from enrolment to Week 24.
All participants were asked to report adverse events, including any additional stressful life events or new treatments, with both passive (reported throughout the trial) and active surveillance (open ended questions at 4, 12 and 24 weeks).
|
Additional Information
Results disclosure agreements
- Principal investigator is a sponsor employee
- Publication restrictions are in place